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1.1 General introduction 
This thesis wiU be divided into four sections. Chapter one 
wiU focus on the general introduction of the human genome 
project including the progress of the project, the using of EST 
approach in studying the human genome, the importance of the 
EST approach, the significance and importance of our adult 
human heart EST project. Identification and characterization of 
one of the cDNA clones that code for the human large subunit 
ribosomal protein L29 (hrpL29) wiU also be described. In 
addition, recent advance and progress in studying the ribosomal 
proteins wiU also be described in chapter one. 
Chapter two wiU describe the strategies and methods we 
used during the large scale EST sequencing and 
characterization of the human large subunit ribosomal protein 
L29. Chapter three wiU present the sequencing result of the 502 
cDNA clones, the catalogue of gene expressed in the adult 
human heart as weU as the gene expression profile of the 
human heart. The results of studying the gene hrpL29 at the 
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DNA and RNA levels, which may provide the information on the 
organization of the gene in the genome and the expression 
characterization of the gene, wiU be described. 
The final chapter wiU discuss the insight we gained during 
the human adult heart EST sequencing. In addition, gene 
organization, gene expression, computer analysis, importance 
and significance of hrpL29 wiU also be discussed in this chapter. 
1.2 The Human genome project 
In the past decades, onfy a few thousand genes have been 
sequenced (Schmidtke and Cooper, 1990), leaving the majority of 
human genes untouched. It is due not ohfy to the lack of efficient 
methodologies but also insufficient manpower for deaMng with the 
miUions of bases of the human genome. In 1990, however, the 
Human Genome Project (HGP) was launched in the United States 
(Watson, 1990). It is aimed at determining the location and 
structure of aU genes of the human genome, of which there are 
estimated to be from 50,000 to 100,000 (Bishop et at, 1974). 
However, problems were soon come out:- Not ordy were size of the 
genome massive - 3.3 X 10^  base pairs of DNA in haploid status, 
but the fact that orJy 3 to 5% of genome was thought to code for 
RNA products. Thus, to expedite the study of expressed genes in 
2 
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human, a pitot project was initiated in 1991 by Dr. Craig Venter to 
test the use of partial cDNA sequences (termed expressed 
sequence tags, or ESTs) as a means to identify genes expressed in 
the human brain (Adams et aL，1991). 
1.3 The EST approach 
The idea of the EST approach assumes that an EST 
represents a segment of a complementary sequence of a single 
mRNA species. In theoiy, the constituents of a cDNA Ubrary 
prepared from a specific tissue should reflect the physiological 
status and the related gene expression profile of that tissue. 
Therefore, it shoiUd be possible to isolate new and previousfy 
uncharacterized genes from the cDNA Ubraries derived from a wide 
variety of ceUs, tissues and organs. 
1.4 Significance ofthe EST approach 
The appearance of the first report on EST sequencing is in 
human brain. After that, there are many such kind of reports on 
EST projects using various human tissues such as brain (Adams 
et oZ., 1992; Khan et aL, 1992; Adams et oZ., 1993a; Adams et aL, 
1993b), hepatocytes (Okubo etal., 1992), heart (Liew, 1993; Liew et 
al” 1994), lung (Sudo et aL’ 1994), testis (Affara et aL，1994) and 
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keratocytes (Konishi et aL, 1994). Sequence data from different 
EST projects have been expanding at a tremendous rate especiaUy 
when the Merck group, which has sequenced cDNA from various 
tissues, takes part in the competition at the end of 1994. The EST 
approach has proven to be a rapid and efficient means of 
discovering genes on a large scale and the EST also provide an 
abundant resource of genetic markers for mapping and 
constructing an expression map of the human genome (WUcox et 
aL, 1991; Khan eto/., 1992). 
Although it has been speculated that middle repetitive 
elements may be important in gene regulation, it has been shown 
with computer simulation that most middle repetitive DNA 
sequences are unavoidable products of dupUcation and divergence 
of inactive portions of genes that serve no purpose but are too 
insignificant to be removed from genomes. Sequencing the 
cDNAs, therefore, wiU by-pass sequencing the "junk'' DNA. 
Another advantage of using cDNA is that only the expressed genes 
are sequenced and the sequencing of introns with repetitive 
elements wUl be kept to a minimum. 
In addition, ESTs can also contribute to the physical 
mapping of the human genome by providing sequence information 
for designing primers to define sequence-tagged sites (STSs) on the 
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genome. An STS is a short, unique DNA sequence which can be 
ampMed by PCR. STSs are becoming standard markers for 
physical map construction (Olson et aL, 1989). 
One of the disadvantage of cDNA sequencing is the 
redundancy of which higUy expressed genes wiU be sequenced 
repeatedty while the rarely expressed genes may not be included in 
the database unless a ku:ge number of cDNA data are anafysed 
(Okubo et aL, 1992; Anderson et al” 1993). Moreover, some 
important controUing sequences which are absent in the cDNA wiU 
not be sequenced. 
1.5 Human heart cDNA sequencing 
The human heart EST sequencing project is a coUaborative 
project between the Chinese University of Hong Kong and the EST 
group at the University of Toronto (Liew, 1993). In contrast to the 
prevalent studies of gene expression in the human brain by 
several EST sequencing groups, genes expressed in the human 
heart remain largely unidentified. Among aU the organs in the 
body the heart is especiaUy chosen because the genes related to 
cardiovascular diseases such as hypertension, atherosclerosis, 
coronary arteiy disease, and heart failure are stiU mysterious. In 
order to tackle the molecular basis of cardiac growth, function, 
5 
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and diseases, we have implemented an EST sequencing project 
using the human heart cDNA Ubraiy which is available 
commerciaUy. The cDNA Ubraiy that we purchased is prepared 
from a normal male adult heart. 
Nowadays, the genetic approach of cardiology is mainty 
focused on the consequences of matformation, metaboUc disorder, 
auto-immune damage and degenerative disease. The heart is not 
onty composed of cardiocytes but also other ceU types such as 
fibroblasts and endotheHal ceUs, etc. As a resvdt, certain abnormal 
genetic signals leading to the development of heart diseases can be 
revealed by comparing the sequences of a normal heart versus 
that of a disease heart cDNA Ubraiy (White and Lalouel, 1988). 
The phenotypic expression of each organ depends on the 
genetic information transcribed from the DNA genome. This 
genetic message, defined as messenger RNA transcripts (mRNAs) 
which confer specificity of expression of an organ, in our case, the 
heart. Since the information carried by each messenger RNA 
transcript is kept by the corresponding cDNA, by sequencing the 




1.6 Significance ofthe human adult heart EST project 
With respect to cardiac development in human, the 
macroscopic and physiological aspects are weU documented; 
however, the underlying molecular mechanism which controls and 
determines cardiac specificity remains largely unknown. In 
human embiyos of 18 or 19 days, mesodermal mesenchymal ceUs 
aggregate to form a primordial heart tube. Upon a series of ceU 
proUferation and involution, the heart waU, composed of 
endocardium, myocardium, and pericardium, arises. By the 22nd 
day, contractions of the primitive heart mark the onset of 
circulating function in the cardiovascukr system (Moore, 1982). 
At the ceUular level, active proUfemtion of undifferentiated 
myogenic ceUs in the embryonic heart occurs. As development 
progresses, the number of dividing ceUs decreases, and synthesis 
of contractile proteins is accentuated. While normal development 
of the heart is thought to rely on stage-dependent activation of a 
panel of muscle-specific genes, the basic question that how do 
mesodermal ceUs initiate the signal for the formation of heart is 
poorly known? Many other questions are stiU unknown. Why does 
the heart retain a consistent pattem of expression? What factors 
induce hypertrophy and subsequent heart failure? These are 
issues of cardinal importance to basic research, as weU as to the 
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future of the health care system. The deUneation of a human 
cardiac cDNA Hbraty wiU provide some direct information for the 
solutions to these questions. For example, the cluster ofhomeobox 
genes for myocardinal ontogenesis and the suppresser genes for 
the non-mitotic activity of cardioqle could be elucidated by DNA 
sequence anafysis. 
1.7 Ribosomal proteins 
1.7.1 The ribosomal constituents 
Ribosomes and their components provide an exceUent 
means of studying the evolution of the organisms, since they are 
essential components for aU ceUs. The ribosome from the three 
kingdoms, eubacteria, eukaryotes and archaebacteria (Woese and 
Fox, 1977; Woese and Olsen, 1986), vaiy considerably in number 
ofconstituents and sedimentation coefficients (Wittmann, 1986). A 
ribosome contains approximately 55 to 85 different ribosomal 
proteins and three to four RNA strands (Table 1.1). 
The eukatyotic ribosome is a ribonucleoprotein complex with 
a sedimentation coefficient of 80S. This complex comprises two 
subunits with sedimentation coefficients of 60S and 40S. The 60S 
subunit consists of approximately 45 different proteins and one 
molecule each of 5S, 5.8S and 28S rRNA, while the 40S subunit is 
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made up ofone 18S rRNA molecule and approximately 30 different 
proteins (Wool and Stoffler, 1974). 
Organism OrganeUe Ribosome No. ofproteins RNAs 
Bacteria 70S 50-60 5S, 16S, 2 3 S ~ 
Hants Chloropku5ts 7 ^ 50-60 5S, 16S, 23S, 
(4.5S) 
"Mitochondria 75S 一 Unknown — 5S,18S, 26S 
Protozoan and Mitochondria ^ 65-75 15S-17S, 21S-
fungi 24S, 
Mammals Mitochondria — 55S 80-90 12S, 16S 
“Eukatyotes 80S 75-90 5S, 5.8S, 17-
(Cytoplasm) 18S, 26S-28S 
Table 1.1 Size and composition ofribosomes (Wool et aZ., 1990). 
The best studied ribosome is that of E.coli in which aU the 
primary structure ofthe 55 ribosomal proteins were known (NoUer 
et aL, 1986; Wittmarui-Liebold et al., 1986). In addition to the 
primary anatysis on their sequences showing that they had no 
statisticaUy significant sequence relationship among each other 
(Wittmann-Liebold et aL, 1984), their shapes and secondajy 
structures have also been investigated (Giri et al, 1984). Recentiy, 
topography of the ribosomal constituents was also gained by the 
analysis ofRNA-RNA, RNA-protein, and protein-protein cross-Unks 
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generated in situ (WaUeczek et cd., 1988; Brimacombe et al,, 1986; 
NoUer et al, 1986; Brockm6Uer and Kamp, 1988; Pohl and 
Wittmann-Liebold, 1988). 
1.7.2 Eukaryotic ribosomal proteins 
Several eukaryotic ribosomal proteins from mammals have 
been sequenced completely (Table 1.2). In addition, a number of 
complete sequences are known for ribosomal proteins from yeast 
(Planta et aL, 1986; Warner, 1989), the African clawed frog 
Xenopus laevis, the brine shrimp Arterma scdina, and the fruit 
Drosophila melanogaster (Wool et aL，1990). Many more partial 
sequences from these and other species have been determined. 
Unfortunately, no complete set of ribosomal proteins for any of 
these eukaiyotic organisms is yet available. Therefore, conclusion 
about the relationship of the eukaryotic ribosome to that of the 
other kingdoms are stiU preUminary. 
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Organism Number of sequenced 
ribosomal proteins 
Rat Hver ^ 
Saccharomyces cereuisiae ^ 
Human ^ 
Mouse 12 
DrosophUa melanogaster |9 
Artemia scdina 2 
Chinese hamster 2 
Xenopus laevis ]3 
Candida utiUs 2 
Tetrahymena ihermophila 2 
Schizosaccharomyces pomhe 6 
Escherichia coli 55 
Table 1.2 Complete sequenced ribosomal proteins from different 
organisms. 
1.8 MammaUan ribosomal proteins 
1.8.1 Evolution of mammaUan ribosomal proteins 
It is suggested for some time that individual ribosomal 
proteins from different eukaryotic species are related and derived 
from the same ancestral genes. This is most convincingly 
substantiated by consideration of the results of comparison of the 
sequences of amino acids in rat and yeast ribosomal proteins, in 
which the largest set of data have been coUected (61 for rat and 31 
for yeast). Even though the two species are evolutionarHy distinct, 
their ribosomal proteins can be correlated. It is found that more 
11 
Introduction 
than 20 of the rat ribosomal proteins had a homologue among the 
yeast sequences and the identities in the aKgnment range from 
from 40 to 80% (Wool et al, 1990). It has been suggested for some 
time that the archaebacterial ribosomes are transition particles in 
the evolution of prokaiyotes and eukaiyotes and that they have 
the properties of both (Matheson, 1985). The amino acid 
sequences of archaebacterial ribosomal proteins, however, are in 
general closer to that of eukajyotes than to the prokaryotes. Until 
recentiy, it is found that the motif of the secondary structure of 
ribosomal proteins are conserved rather than the primary 
sequences (NoUer, 1984) but it is not to say that no conservation is 
found at the level of the primaiy sequence. Most of the conserved 
sequences tend to be in the non-heUcal regions and there is 
evidence that they are important for function. It is, therefore, 
possible that onty the functionaUy important amino acids in 
ribosomal proteins wiU be conserved. 
1.8.2 Significance of mammalian ribosomal proteins 
To determine the sequences of amino acids in aU of the 
proteins in a single mammaUan species, for example rat or 
human, is a tedious, time-consuming and expensive project. The 
data, however, are wcxy important since without the sequences aU 
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anatytical and structural chemistry is kiden with theory. The 
primary sequence is also an absolute prerequisite for determining 
the structure of mammaUan ribosomes which is, in tum, essential 
for understanding their functions. The fact that this information is 
akeady available for Escherichia coli ribosomes (Wittmann-Liebold, 
1984) do not diminish the importance of obtaining the data for 
mammaUan ribosomes. Indeed, each set is Ukely to enhance the 
value ofthe other. Thus, the whole set ofamino acid sequences for 
a particular mammaUan species is very important for us to 
understand how the organeUe functions in protein synthesis. 
Furthermore, the data may also help us in understanding the 
evolution of ribosomes and in unraveUing the function of the 
ribosomal proteins. It also helps us in fathoming the reasons for 
the discrepancy between the number of ribosomal proteins in 
B,coli，which has 55, and in eukatyotes, which has 70-80 (Otaka 
et o/., 1981; Otaka et cd., 1984), in defining the rules that govem 
the interaction of the ribosomal proteins and the rRNAs, and in 
uncovering the amino acid sequences that direct the ribosomal 
proteins to the nucleolus for assembly on nascent rRNA. 
13 
Introduction 
1.9 Possible functional roles of ribosomal protein 
It is suggested for many years that ribosomal proteins can 
stabiUze weak tertiaiy structure interactions or serve as a cross-
Unk holding domains of RNA in the correct relative orientation. 
Until 1981, an experiment by Backendorf et aL, showed that a 
DNA octamer analogue of the mRNA Shine-Dalgamo sequence is 
able to bind to 30S subunits onty if S21 is present. S21 itsetf can 
either bind directiy to an mRNA-rRNA heUcal segment or stabiUze 
a 16S rRNA conformation in which the Shine-Dalgamo sequence 
is accessible to the mRNA. In either case, the system provides an 
exceUent opportunity to examine the way in which a ribosomal 
protein stabiUzes a functional RNA-RNA interaction. 
Scientists working on ribosomes suggested the RNA 
structural changes are very important for the ribosome cycle. 
CoupUng of GTP hydrolysis to translocation or tRNA binding 
requires some sort of co-operative or aUosteric conformational 
change in the ribosome, and slow, unimolecular rearrangements 
take place during initiation complex formation (Wintermeyer and 
Gualerzi, 1983). Ribosomal proteins, thus, may facilitate such 
conformational changes either by lowering the activation energy 
for switching between structures or by preventing incorrect 
structures from forming. Such function has been proposed to 
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account for the stimulation of protein synthesis and the 
uncoupUng of GTPase activity by L l l (CundMe, 1986). 
It is weU known that the RNA component of the RNase P, a 
ribo^one, can recognize and cleave the tRNA precursors in the 
absence of the basic protein component at a very high salt 
concentration (Gardiner et cd,, 1985). When comparing the activity 
of the holoenzyme and the RNA alone in the single-turnover 
experiment, it is suggested that the function ofthe basic protein is 
to provide a controUed amount of positive charge near the tRNA 
substrate-binding site, so that the substrate can bind and tum 
over rapidty at the physiological salt concentration (Reich et al, 
1988). Since the condition of RNA-protein interaction in the 
ribosome is quite similar to that of RNase P (interaction between 
an RNA and a basic protein), similar roles for ribosomaI proteins in 
aiding the turnover of tRNA or aHgmnent of mRNA on the 
ribosome can be imagined. Moreover, the positive charge on the 
ribosome may also aUow the RNA to adopt a more compact 
conformation and thus promote ribosome function in a non-
specific way. 
In the prokatyotic system, researchers worked on the E.coli 
50S reconstitution in order to define the minimum ribosomal 
proteins required for the peptidyltransferase activity and 
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conduded that L2, L3, L4. L15, L16 and the 23S rRNA constitute 
the peptidyltransferase center (Nierhaus, 1980; Hampl et cd., 1981; 
Schuke and Nierhaus, 1982). In addition, subsequent genetic 
studies also demonstrated that L15 is dispensable for ceU growth 
(Lotti etaL, 1983; Ito etal., 1984). 
1.10 Nomenclature of ribosomal proteins 
The name of ribosomal proteins from archaebacteria or 
eukaiyotes were assigned systematicaUy base on their similarity to 
the E.coli counterpart. The systematic name was composed of (i) 
three characters to describe the organisms from which the 
ribosomal protein derived. For example, Eco (Escherichia co/i), Hma 
(Hcdobacterium marisomortui^ and Rno (Rattus norvegicus); (ii) the 
prefix L or S to indicate whether the ribosomal protein is 
originated from the large subunit or smaU subunit respectively, 
and (iii) the same number as for the equivalent E.coli proteins. 
Therefore, according to this system, MvaL23 is the ribosomal 
protein of M. vannielii that is homologous to protein L23 of B.coli 
The total number of ribosomal proteins, however, is not the 
same among different organisms. For instance, there are about 80 
evQcaiyotic ribosomal proteins (Wool et al, 1979; Wool et al, 
1990) and only 55 is found in E.coli (Otaka et al, 1981; Otaka et 
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al, 1984) (Table 1.1). Therefore, it is sometimes difficult to assign 
a name for a eukaiyotic ribosomal protein in cases where there are 
no significant homologies between the eukaryotic and prokaryotic 
ribosomal proteins. When the ribosomal proteins deriving from the 
archaebacterial and eukaryotic have no clear homology with the 
eubacterial counterpart, the vulgar name (rat, mou[se], ham[ster], 
etc.) has been kept to aUow for easy differentiation. However, there 
are no unique naming system for the eukaryotic ribosomal 
proteins. 
1.11 The theme ofthe thesis 
The aim of this thesis is to report the sequencing of 
the 502 cDNA clones from the human normal adult male heart, 
and is designed at reveaUng the protein expression profile and 
novel genes related to the heart disease. During the large scale 
partial sequence analysis, a cDNA clone which shows simUarity 
to the rat large subunit ribosomal protein L29 (Rat L29) (Chan 
et aL, 1993) was found. In addition to report the analysis of the 
502 ESTs, the characterization of the hrpL29 at the RNA and 
DNA levels wiU be described. It is hoped that this basic research 
wiU give us some insights on the function of this protein in 
human. 
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Chapter Two 
Materials and Methods 
2.1 Cycle sequencing 
2.1.1 Plating out the cDNA library 
Before plating, a single E.coli colony fY1090) was 
incubated in 20ml LB medium supplemented with 0.2% 
maltose, lOmM MgSO4 and lOOpg/ml ampiciUin at 37^C for 16 
hours with gentle shaking at 200 r.p.m.. Then the ceUs were 
coUected by centrifugation at 5K r.p.m. (Beckman rotor 20-2) for 
10 minutes at 4°C. The peUet was resuspended with 10 ml of 
lOmM MgSO4. For better performance, the suspension was 
stored at 4°C and used within one month. For infection, the 
phages Agtll were plated at low density (-50-100 independent 
plaques per 100mm petri dish), the phage cDNA Ubrary was 
mixed with 200 i^l Y1090 plating ceU and the mixture was 
incubated at 37� for 20 minutes. Thereafter, the mixture was 
combined with 9jil IPTG (200mM), 40 i^l X-gaI 
(50mg/ml,Promega) and 6pl ampiciUin (50mg/ml). Then, 3ml of 
0.4% agarose was added at 50�� i n t o the infection mixture and 
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mixed thoroughly. The agarose was poured onto a LB plate 
prewarmed at 42°C and incubated at 37°C overnight. The white 
plaques were picked using pasteur pipettes and the plaques 
were placed in 50 i^l suspension medium to elute the phage 
(Sambrook et al’ 1989) for at least two hours at 4�C. 
2.1.2 Amplification of the cDNA clones by PCR 
Primers flanking the Xgtll (Appendix) EcoRl site on the 
lambda phage were used to ampUfy the cDNA clones. 
Forward: 5,-ATTGGTGGCGACGACTCCTGGA-3, 
Reverse: 5'-TTTGACACCAGACCAACTGGTA-3' 
In the 50^1 PCR mixture, there were 2\il of phage suspension, 
2.5 i^M of each of the forward and reverse primer, 5 i^l 10X 
reaction buffer (Pharmacia), 0.5 l^l Taq polymerase (2.5U/pl, 
Pharmacia), 5p<l 2mM dNTP (Pharmacia) and double distiUed 
water. The temperature profile was as foUows: 
1. 94�C 5 min. 
2. 95�C 36 sec. 
3. 50�C 36 sec. 
4. 72�C 1 min. 30 sec. 
5. 72�C 5 min. 
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Steps 2 to 4 were repeated for 30 times. 
2.1.3 Purification and quantitation of the PCR product 
FoUowing the PCR, 2^1 of the atnpUfied DNA were analyzed 
on a 1% agarose gel. If a visible band was obtained, the DNA 
would be concentrated and purified by fUtration using the 
Ultrafree®-MC 30,000 NMWL filter unit (MiUipore). 
2.1.4 Cycle DNA sequencing 
The human adult male heart Agtll cDNA Ubrary was 
purchased from Clontech. Partial sequencing of cDNA clones 
proceeded as foUows (Liew, 1993). Approximately 150 to 200ng of 
PCR product were used for cycle sequencing (Cyclist Taq DNA 
Sequencing Kit, Stratagene, La JoUa, CA), in the presence of 5 
pmol of the fluorescein-conjugated primer nested within the PCR 
forward primer: Forward: fluorescein-5'-
GGTGGCGACGACTCCTGAGCC-3'. Sequencing reactions (10 [d in 
total volume) were cycled for 25 cycles at 94�C, 36 sec; 50�C, 36 
sec; 72°C, 1 min. 24 sec. and a 10 minutes final extension at 72�C. 
The reactions were terminated by addition of 5 pl stop solution 
(95% formamide, 20 mM EDTA and 10 mg/ml blue dextran) and 
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samples were separated on 6% acrylamide gel using a Pharmacia 
ALF Sequencer. 
Sequence comparisons against the non-redundant Genbank 
and EMBL nucleotide and protein databases were performed 
through the BLAST network server (Akschul et aJL, 1990; Gish and 
States, 1993) at the National Center for Biotechnology Information 
(NCBI). The parameters were set to detect matches with 
statisticaUy significant scores, i.e. B=20, E=0.75, and V=25. Data 
compilation and management were accomplished by using dBase 
V^  (Borland). 
2.2 Cloning of hrpL29 in pUC18 cloning vector (Appendix) 
2.2.1 Amplification of the phage by plate lysate 
The procedures for atnpMcation of the phage were 
performed as described previously (refer to section 2.1.1) but the 
phage was plated at a confluent density. After 42°C incubation 
overnight, 3ml suspension medium was added into the plates 
and the plates were sealed with parafihn. The plates were 
incubated at 4°C for 3 hours with gentle shaking. Afterwards, 
the suspension was transferred into a microfuge tube and 100|il 
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chloroform was added into it to lyse the bacterial host ceUs. The 
tube was then centrifuged at 10,000xg for 10 minutes at 4°C 
and the supernatant was transferred into a new microfuge tube. 
To preserve the phage, a drop of chloroform was added into the 
supernatant and it was either used or stored at 4°C. 
2.2.2 Amplification of the insert by PCR 
The conditions of ampUfication of the insert by PCR were 
the same as that described previously (refer to the section 
2.1.2). 
2.3 Screening for hrpL29 transformant 
2.3.1 Mini-preparation of plasmid DNA (Sambrook et aZ, 
1989) 
A transformant was inoculated in 3ml LB medium 
supplemented with appropriate antibiotics. The bacteria were 
aUowed to grow at 3 7 � � w i t h gentle shaking at 250 r.p.m. 
overnight. The overnight culture (1.5ml) was transferred into a 
microfuge tube and centrifuged at 4,000xg for one minute. The 
supernatant was aspirated and the ceU peUet was resuspended 
in 100pl ice-cold Solution I (50mM glucose, 25mM Tris-HCL 
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pH8.0, lOmM EDTA pH8.0). The bacterial ceUs were left on ice 
for 10 minutes. Then 200 i^l Solution II (0.2M NaOH, l%SDS) 
was added into the ceUs and the contents were mixed by 
inverting the tube up and down for five times. After the ceUs 
were incubated on ice for 5 minutes, 150 i^l of ice-cold Solution 
III (60ml 5M potassium acetate, 11.5ml glacial acetic acid and 
28.5ml water in each lOOml) was added into the lysate. The 
tube was vortexed in an inverted position for several seconds 
and the lysate was left on ice for 30 minutes. Chromosomal 
DNA and ceU debris were removed by centrifugation at 10,000xg 
for 10 minutes at 4°C. The clear supernatant was transferred 
into a new microfuge tube and two volumes of ice-cold absolute 
alcohol were added into it. The plasmid DNA was aUowed to 
precipitated at -20�C for an hour before the DNA was coUected 
by centrifugation at 10,000xg for 10 minutes at 4°C. To remove 
the salt, the DNA peUet was washed with 1ml ice-cold 70% 
ethanol and re-centrifuged at 10,000xg for 5 minutes at 4°C. 
The plasmid DNA was vacuum dried for 20 minutes and then 
dissolved in 20^1 sterile double distiUed water supplemented 
with RNase(20^ig/ml). 
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2.3.2 Large scale preparation of plasmid DNA 
Large scale preparation of plasmid DNA was prepared by 
using Qiagen columns which were prepacked with anion-
exchange resin. A single bacterial colony carrying the plasmid of 
interest was inoculated into 250ml LB medium supplemented 
with the appropriate antibiotics. The culture was aUowed to 
grow at 37°C ovemight with gentle shaking at 250 r.p.m.. The 
bacterial ceUs were harvested by centrifugation at 5,000 r.p.m. 
(Beckman rotor 12-2) for 10 minutes at 4°C. Afterwards, the 
ceUs were resuspended in 4ml ice-cold P1 buffer (lOO^ig/ml 
RNase A in 50mM Tris-HCL, lOmM EDTA pH 8.0). Vigorous 
votexing was essential. Then, 4ml P2 buffer (l%SDS, 200mM 
NaOH) was added. The contents were mixed by inverting the 
tube several times and the tube was incubated at room 
temperature for 5 minutes. After the incubation, 4ml chiUed P3 
buffer ( 3M potassium acetate, pH 5.5) was added into the 
mixture. The contents were mixed by inverting the tube several 
times and the tube was incubated on ice for 15 minutes, the 
bacterial lysate was centxifuged at 30,000xg (Beckman rotor 12-
2) for 30 minutes at 4°C to remove the ceU debris. 
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A QIAGEN-Tip 100 column was equiUbrated with 2.0ml 
QB solution (750mM NaCl, 50mM MOPS pH 7.0, 15% ethanol). 
The supematant was then appUed carefuUy onto the column. 
After washing the column twice with 4ml QC solution (l.OM 
NaCl, 50mM MOPS pH 7.0, 15% ethanol), the plasmid DNA was 
eluted by 2.0ml QF solution (1.2M NaCl, 50mM MOPS pH 8.0, 
15% ethanol). Then, 1ml isopropanol was added and the 
plasmid DNA was harvested by centrifugation at 30,000xg 
(Beckman rotor 20-2) for 30 minutes at 4^C. The DNA peUet was 
then washed with chiUed 70% ethanol and air-dried for 30 
minutes. The plasmid DNA was fmaUy dissolved in an 
appropriate volume of sterile double distQled water for 
immediate use or long-term storage at -20X. 
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2.4 Primer design for cloning of an intron of hrpL29 
The intron specific primers (Forward: 5,-
TAGGGCCTGCAGCCAAGTCCAAGAACCAC-3'; Reverse:5'-
TAGGGCAAGCTTGAGATTCGTATCTTTGTGAT-30 within the 
coding region of hrpL29 were designed and synthesized within 
the first 100 bases coding region to give an intron specific 
fragment of about 400 base pairs. An end clamp sequence of 
TAG GGC was added in the beginning of both forward and 
reverse primers and two cloning sites, Pstl and HindIII, were 
also included in the forward and reverse primers respectively. 
2.5 Isolation of the intron of hrpL29 by PCR 
PCR was performed with 700ng human genomic DNA in a 
total volume of 50^1 containing 1.5mM MgCk, lXPCR 
buffer(GibcoBRL), 200 i^M dNTP mix (Pharmacia), 0.5 i^M of each 
forward and reverse primer, and 2.5 units of Taq polymerase 
(Pharmacia). AU PCRs were carried out in a programmable 
thermocycler (Pharmacia) under an initial denaturation 
condition of 2 minutes at 94°C and then 38 cycles of 38 sec. at 
94°C, 38 sec. at 5rC, lmin. 28 sec. at 72°C. A 10 minute final 
extension at 72°C was also included at the end of the cycles. 
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2.6 Restricted endonuclease digestion 
The DNA digestion was carried out in a total volume of not 
greater than 25^d containing an appropriate amount of One-
Phor-AU PLUS buffer (Pharmacia), 0.5jil of the chosen 
endonucleases (Pharmacia), approximately one ^g of DNA and 
sterile double distiUed water. GeneraUy, the volume of the 
endonuclease added was not greater than one-tenth of the total 
reaction volume and was added last into the digestion mixture. 
The digestion was normaUy performed at 3 7 � � f o r three hours. 
After the digestion, the endonucleases were heat inactivated at 
either 65�C for 20 minutes or 85�C for 30 minutes. After 
heating, the reactions were cooled for 20 minutes at room 
temperature. 
2.7 Purification of DNA from the agarose gel 
Purification of DNA was carried out by using the 
GENECLEAN" II kit. The DNA was firstly electrophoresed in 1% 
TAE agarose gel (0.04M Tris-acetate, 0.001M EDTA, 1% 
agarose) and the ethidium bromide stained DNA of interest was 
excised from the gel using a cleaned razor blade under a long-
wave UV Ught. The gel sUce was placed in a microfuge tube and 
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3 volumes of 6M sodium iodide (Bio 101 Inc., La JoUa, U.S.A.) 
was added into the tube. The tube was then incubated at 55®C 
for 10 minutes with occasionaUy shaking until the sUce was 
completely dissolved. Afterwards, 5 i^l GLASSMILK provided in 
the GENECLEAN kit was added and gentle shaking was used to 
mix the content. The mixture was left at room temperature for 
15 minutes. Upon incubation for 10 minutes, the mixture was 
subjected to centrifugation at 15,000xg for 30 sec. The 
supernatant was removed and the peUet was resuspended in 
200pl ice-cold NEW WASH provided in the kit. The mixture was 
centrifuged again and the peUet was washed twice with 200^1 
ice-cold NEW WASH. To elute the bound DNA, 20 1^ of sterile 
double distQled water was added to resuspended the peUet and 
the tube was incubated at 55°C for 10 minutes. After 
centrifugation at 15,000xg for 5 minutes, the supernatant 
containing the DNA was saved and quantitated by 
electrophoresis in 1% TBE agarose gel. 
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2.8 Dephosphorylation of linearized plasmid DNA 
The cloning vector of interest was digested with the 
appropriate endonucleases and the restricted DNA fragment 
was subjected to purification using the GENECLEAN" II Kit. 
Then the 5,-phosphate group of the purified DNA fragment was 
dephosphorylated in 25ul reaction volume containing l^il CaLf 
Intestinal ADcaHne Phosphatase (lunit/^1, Promega), and 2.5 t^l 
Catf Intestinal AU a^Hne Phosphatase 10X reaction buffer (0.5M 
Tris-HCl, pH 9.0, lOmM MgCl2, lmM ZnCl2, lOmM spermidine). 
The reaction mixture was then incubated at 37°C for 30 
minutes and the DNA was purified using the GENECLEAN^^ II 
Kit. 
2.9 DNA ligation 
The cohesive-end DNA Ugation was performed using the 
T4 DNA Ugase (lU/jil, GIBCO BRL), the recommended molar 
ratio of the insert to vector was 3:1. The 20 [d Ugation reaction 
contained l^il T4 DNA Ugase, about 100ng total DNA (insert and 
vector in 3:1 ratio), 4^ 1 5x Ugation buffer (GIBCO BRL) and 
sterile double distiUed water. The Ugation was carried out at 
16°C overnight. 
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2.10 Preparation of competent bacterial ceUs for 
transformation (Hanahan, 1985) 
A single bacterial ceU (Escherichia coli JM109) was 
inoculated in 1.5ml LB medium supplemented with appropriate 
antibiotics and the culture was aUowed to grow ovemight at 
37^C with gentle shaking at 250 r.p.m.. Thereafter, 250^1 of the 
ovemight culture was transferred into 25ml LB medium 
supplemented with appropriate antibiotics and the culture was 
left for growth at 3 7 � � w i t h s aking for 3 hours until reaching 
the log phase. Then the ceUs were coUected by centrifugation at 
3,000 r.p.m. (Beckman rotor 20-2) for 15 minutes at 4°C. The 
ceU peUet was resuspended in one-third volume of the original 
culture o fRFl buffer (lOOmM RbCl, 50mM MnCl2.4H2O, 30mM 
potassium acetate, lOmM CaCl2.2H2O, 15% w/v glycerol, 
pH5.8, sterile-filtered) and the bacterial ceUs were incubated on 
ice for 20 minutes before harvesting by centrifugation at 
3,000r.p.m. (Beckman rotor 20-2) for 15 minutes at 4°C. The 
peUet was then resuspended in 1/12.5 volume of the original 
culture of RF2 buffer (lOmM MOPS, lOmM RbCl, 75mM 
CaCl2.2H2O, 15% w/v glycerol, pH6.8, autoclaved). The ceUs 
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were chiUed on ice for another 15 minutes and aUquoted into 
the pre-chiUed microfuge tubes in 500pl fraction. The competent 
bacterial ceUs were then rapidly frozen by Uquid nitrogen and 
stored at -70^C. 
2.11 Plasmid DNA Transformation 
Frozen competent ceUs were thawed on ice and the 
plasmid DNA of less than 20 1^ was added into the competent 
ceUs. After mixing thoroughly, the tube was incubated on ice for 
20 minutes and then the ceUs were heat shocked at 42°C for 
exactly 90 sec. Afterwards, the tube was immediately put on ice 
for 2 minutes and 800 i^l LBC (lOml LB medium supplemented 
with 0.2ml lM glucose) was added into the ceU suspension. The 
ceUs were then incubated at 37°C for 30 minutes with very 
gentle shaking. FinaUy, the transformation mixture was plated 
on LB-plates containing appropriate antibiotics. 
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2.12 Unicycle DNA sequencing by T7 polymerase 
(Pharmacia) 
5-10 ^g of DNA template in 32 1^ was mixed with 8 i^l of 2 
M NaOH. The tube was vortexed gently, then centrifuged briefly. 
After incubating at room temperature for 10 minutes, 7 \il of 3M 
sodium acetate (pH 4.8), 4 1^ of deionized water and 120 1^ of 
100% ethanol were added. The tube was placed at -20°C for 15 
minutes and then centrifuged for 15 minutes at 4®C. The 
supematant was discarded and the peUet was washed by 70% 
ethanol. The peUet was resuspended in 10 1^ of distiUed water 
and 4-6 pmol of fluorescent primer and 2 1^ anneaUng buffer 
was added to a volume of 14 \il. The anneaUng reaction was 
preheated at 65°C for 5 minutes and then immediately placed at 
37°C for 10 minutes. 1 ^ 1 of extension buffer, 3 i^l of DMSO and 
2 jil of T7 polymerase (8 U/2 1^ of dilution buffer) were added. 
4.5 pl of this mixture was immediately pipetted into each of the 
prewarmed sequencing mixes containing 2.5 pl dNTPs and 
ddNTP. The sequencing reactions were incubated at 3 7 � � f o r 5 
minutes and stopped by the "stop solution" (95% formamide, 20 
mM EDTA, 10 mg/ml blue dextran). 
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2.13 Synthesis of radiolabeUed DNA probe 
The radiolabeUed DNA probe was synthesized using the 
Megaprime DNA LabeUing System (Amersham). In this 
procedure 25 ng DNA dissolved in double distiUed water was 
mixed with 5 \il primer solution. The resulting solution was 
made up to 50 1^ with double distiUed water. The mixture was 
then boiled at 100^C for 5 minutes. After the addition of 10 ^ d 
labeUing buffer, 5 i^l a-32p-dCTP (-3,000Ci/mmol, Amersham) 
and 2 \il Klenow fragment, the contents were mixed gently by 
pipetting up and down, foUowed by incubation at 37°C for 10 
minutes. The reaction was stopped by adding 5 pl of 0.2 M 
EDTA. 
A NucTrapTM push column (Stratagene Cloning System) 
was equiUbrated with 70 i^l TE buffer (100 mM NaCl, 20 mM 
Tris-HCl, 10 mM EDTA). a-32p-dCTP that had not been 
incorporated into the probe was removed by applying the 
reaction mixture into the equiUbrated column. After the sample 
appUcation, the eluate was coUected in a microfuge tube. Then, 
70 nl of TE buffer was added into the column to elute the 
radiolabeUed probe that was stiU bound to the column. A total of 
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about 140^1 probe with specific activity of about 1.8xl0^ 
dpm/^g could be coUected. 
2.14 Oligonucleotide synthesis, deprotection and 
purification 
2.14.1 OUgonudeotide 83rnthesi8 
The oUgonucleotides were synthesized using the Gene 
Assembler® Special machine (Pharmacia). Fresh amidites, 
reagents and solvents were firstiy connected to the machine. The 
amidites and anhydrous acetonitrile (ACN) were kept from 
moisture by fiUing up the amidite vials and ACN bottle with argon 
by adjusting the gas pressure to 0.1 bar. The DNA sequence was 
entered under the SEQUENCE EDITOR and the synthesis was 
started after choosing the decided synthesis conditions. For 
normal synthesis rate, the economic scale was chosen. However, if 
a faster synthesis was needed (but it would consume more 
amidites), the economy scale was not chosen. Moreover, the final 
detritylation was selected if a normal primer was synthesized but it 
was not done for fluorescein-conjugated primers. 
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2.14.2 Deprotection and purification of oUgonudeotides 
The oUgo-support cassette was removed from the column 
reactor after the synthesis and was placed into a 1.5 ml pkistic 
microfuge tube. The tube was centrifuged to remove any trapped 
acetonitrile from the cassette. The cassette was then transferred 
to a new 1.5 ml screw-top Sarstedt tube and 1 ml of 58% 
ammonia solution was added into the tube. The cap was tightJy 
replaced and the tube was centrifuged to ensure that the cassette 
was immersed in the ammonia solution. The Sarstedt tube 
containing the cassette was placed inside a smaU screw-capped 
gkiss bottle containing 1 ml of 58% ammonia solution. The sealed 
^ s s bottle was placed in a water bath at 7 0 � � a n d the 
deprotection was aUowed for 30 minutes. The Sarstedt tube was 
removed and cooled by placing it on ice for 15 minutes. The 
cassette was then removed from the Sarstedt tube and was placed 
into a new 1.5 ml microfuge tube. The residual amount of 
ammonium solution (containing the oUgonucleotide) on the 
cassette was coUected by centrifugation. The crude oUgonucleotide 
mixture was then passed through a NAPrM-10 column (Sephadex 
G-25, Pharmacia) equiHbrated with three column-volumes of 
sterile double distiUed water for desalting by gravitation. The 
purified oUgonucleotide was coUected by eluting the column with 
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1.5 ml sterile double distiUed water and the oUgonucleotide was 
stored at -20X. For the fluorescein-conjugated primers, they were 
wrapped with alvuninium foil to prevent photo-degradation. 
2.15 Southem analysis 
2.15.1 Isolation of genomic DNA from leukocytes (CiuUa et 
aL, 1988) 
10 ml human blood was obtained in a Falcon tube with 
lOOpl 0.5M EDTA. 5 ml human blood was added into 45 ml 
solution A (0.32M sucrose, lOmM Tris-HCl, pH7.5, 5mM MgCh, 
1% Triton X-100). The tube was then chiUed on ice for 15 - 20 
minutes until the solution become clear. The contents were 
centrifuged at 3,200 r.p.m. or l,500xg for 10 minutes at 4�C. The 
supernatant was discarded and the peUet was washed with 45 ml 
solution A and re-centrifuged at 3,200 r.p.m. or l,500xg for 
another 10 minutes. The peUet was resuspended in 5 ml solution 
B (4M guaxudine thiocyanate, 25mM sodium acetate, pH4.8, 
0.84% p-mercaptoethanol) by gentle rocking for 20 minutes. 
Afterwards, the genomic DNA was precipitated at room 
temperature with gentle shaking by adding 1 volume of 
isopropanol and incubated until white theads of DNA were seen. 
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The peUet of DNA was coUected by centrifugation at 3,200 r.p.m. or 
l,500xg for 25 minutes at 4oC. The DNA was washed several 
times with 70% ethanol until the smeU of p-mercaptoethanol 
dissipated. The DNA was then dried briefly in air. Afterwards, 
200nl ofTE buffer (lOmM Tris-HCl, lmM EDTA, pH8.0) was used 
to dissolve the DNA which could then be quantitated and stored at 
-20�C. 
2.15.2 Restricted digestion and fractionation ofgenomic DNA 
Thirteen microgram genomic DNA was restricted either with 
BcoRl，Hindm，BcwiHl or PstL, and the samples were then 
fractionated by 0.7% agarose gel in TBE buffer. After 
electrophoresis, the unused areas of the gel was cut out and the 
bottom right-hand comer was nicked in order to orient the gel. 
The gel was then used for the Southern blotting. 
2.15.3 Southem transfer of DNA onto a membrane support 
The DNA was denatured by soaking the gel in several 
volumes of neutraUzation solution (1.5M NaCl, 0.5N NaOH) for 45 
minutes with constant and gentle agitation. The gel was then 
rinsed briefly in double distiUed water and was neutralized by 
soaking for 30 minutes in several volumes of neutraUzation 
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solution (lM Tris, pH7.4, 1.5M NaCl) at room temperature with 
constant and gentle agitation. The gel was soaked in another tank 
of neutraMzation solution for another 15 minutes. A piece of 
Whatman 3MM filter paper was kid around a glass plate to form a 
support that was longer and wider than the gel. The wrapped 
support was placed inside a large baking dish. The dish was fiUed 
with transfer buffer，10X SSC (1.5M NaCl, 1.6M sodium citrate, 
pH7.0) until the level of the liquid reached ahnost to the top of the 
support. When the 3MM paper on the top of the support was 
thoroughty wet, aU air bubbles were smoothed out with a glass 
rod. A piece of new PVDF membrane (MiUipore) was cut, about 
1mm larger than the gel in both dimensions. The membrane 
should be pre-wet with absolute ethanol and then rinsed with 
double distiUed water. The membrane was then soaked with 
transfer buffer (lOX SSC) for 20 minutes. The gel was removed 
from the neutraHzation solution. The gel was inverted so that its 
underside was now uppermost. The inverted gel was on the 
support so that it was centered on the wet 3MM papers. AU the 
bubbles between the 3MM paper and the gel were removed. The 
gel was surrounded with Saran Wrap to prevent any Kquid from 
moving directly from the reservoir to the paper towels placed on 
top of the gel or else it would short circuit. The wet PVDF 
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membrane was pkiced on top of the gel so that the cut comers 
were aUgned. Two pieces of 3MM paper, the same size as the gel, 
pre-wet with 2X SSC, were placed on top of the wet membrane. A 
stack of paper towels (5 - 8 cm high) just smaUer than the 3MM 
papers was put on the 3MM papers. A glass plate together with a 
500g weight was placed on top of the stack. The transfer of DNA 
was aUowed to proceed for 8 - 24 hours. The DNA was transferred 
onto a PVDF membrane (Immobilon™-N from MiUipore) by 
capiUary action in 10X SSC. Before the membrane was removed, 
the position of weUs were marked onto the membrane by using a 
pencil. The membrane was soaked in 6X SSC for 5 minutes at 
room temperature to remove any pieces of agarose sticking to the 
membrane. The membrane was aUowed to diy on paper towels for 
at least 30 minutes. The DNA on the membrane was then fixed by 
exposing to UV-crossUnker (254nm) for 2 minutes or baking at 
80°C for 2 hour. The membrane was stored at room temperature 
until hybridization was performed. 
2.15.4 Prehybridization ofthe Southern blot 
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The prepared membranes were put into a plastic box with 
each membrane separated by a wire mesh. Prehybridization 
buffer [50% formamide, 6X SSC, 5X Denhardt's solution {lOX 
Denhardt's solution stock: 0.2% bovine serum albumin (Fraction 
V, Sigma), 0.2% FicoU (Type 400, Sigma), 0.2% 
polyvinylpyrroUdone (Molecular Biology Reagent, Sigma)}, 
lOOmg/ml denatured sahnon sperm DNA (Sigma) (or denatured 
calf thymus DNA), 0.1% SDS] was added until the membranes 
were completely immersed. The contents were shaken overnight 
at 42�C. 
2.15.5 Hybridization ofthe Southem blot 
On the next day, the prehybridization buffer was discarded 
and replaced by fresWy prepared hybridization buffer [50% 
formamide, 6X SSC, lOOmg/ml denatured sahnon sperm DNA 
(Sigma) (or denatured calf thymus DNA), 0.1% SDS]. The 
radiolabeUed probe prepared in section 2.13 was denatured by 
heating at 100^0 for 5 minutes and chiUed on ice immediately. 
The denatured probe was added into the hybridization mixture 
immediately. The contents were shaken again at 42°C overnight. 
To reduce any background signal, the membrane was first washed 
with IX SSC (0.75M NaCl, 0.075M txisodium citrate)/0.1% SDS at 
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room temperature for 10 - 20 minutes. The membrane was then 
washed with 0.2X SSC/0.1% SDS at room temperature for about 
10 minutes until a constant reading was obtained from a portable 
Geiger-counter. The membrane was aUowed to dry on a sheet of 
3MM paper at room temperature. Orientation of the membrane 
was made with radioactive ink containing 2^p. The filters were 
fixed on a sheet of 3MM paper with adhesives. The 3MM paper 
was wrapped with ding film. The kbeUed signal was exposed to X-
ray fflm in a cassette at - 7 0 � � . The fflm was developed using a 
developer piquid X-ray developer, T ^ e 2, Kodak, Cat. No. 
4051298) and fixing solutions (Uquid X-ray fixer and replenisher, 
Kodak, Cat. No. 4051611). 
2.16 Northem analysis 
2.16.1 Isolation of total RNA by using the AGPC-RNA method 
(Chomczynski and Sacchi, 1987, modified) 
AU the apparatus needed for preparation of RNA were baked 
at 18QoC overnight (plastic-ware were soaked with 5% SDS 
overnight) and the reagents were autoclaved with the addition of 
0.1% DEPC in order to remove any RNase. For preparation of 
RNA from 2 g of tissue, 10 ml of GT buffer (25g Guanidium 
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thiocyanate, 1.76ml 0.75M sodium citrate, 0.36ml 
mercaptoethanol, 25ml water) was added. The tissue was 
homogenized and then centrifuged to removed any unbroken 
tissue. 0.52 ml 10% NLS was added into the mixture. Afterwards, 
1 ml sodium acetate (2M, pH4.0), 10 ml phenol (Tris-saturated), 2 
ml chloroform/iso-AA (49:1) were added in order into the mixture 
of the broken tissue. The contents were vortexed for 15 - 20 
seconds, cooled on ice for 15 minutes, and centrifuged at 10,000g 
for 20 minutes. The supernatant was transferred to a new tube 
while the peUet was discarded. One volume of isopropanol was 
added to the supernatant which was placed at - 2 0 � � f o r 45 
minutes. 
The contents were centrifuged at 10,000 g for 30 minutes at 
4oC and the supernatant was discarded. The peUet was dissolved 
in 1 ml EB (GT, 0.052ml/ml 10% NLS). Then 0.1 volume of 
sodium acetate (2M, pH4.0) and 1 volume of 
phenol/chloroform/iso-AA were added to the dissolved peUet. The 
contents were vortexed for 20 seconds and was centrifuged at 
13,000 r.p.m. (20,000g) for 5 minutes at 4�C. The aqueous layer 
was coUected in a new tube without disturbing the protein layer. 
2.5 volumes of absolute ethanol was added to precipitate the RNA 
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at -20°C for 1 hour. The precipitated RNA was coUected by 
centrifugation which was then washed with 70% ethanol. The 
extracted RNA was dissolved in 0.5% SDS or DEPC-txeated water 
and stored at -70°C. The integrity of the extracted RNA could be 
anafysed by electrophoresing by formaldehyde agarose gel in 
formaldehyde running buffer or 1% TAE agarose gel in TAE buffer. 
For the preparation RNA from ceU culture, the same protocol 
could be used except the initial procedures. The culture media of 
the monolayer ceU culture (175cm2) was removed. Five milliliters 
of EB was used to rinse the ceUs out of the culture flask. A 23G 
gauge syringe needle was used to shear the DNA. Then 
phenol/ chloroform extraction could be performed and the RNA 
was extracted as described previousty. 
2.16.2 Separation of total RNA by electrophoresis and 
transfer onto a membrane support 
The resolving gel was prepared by melting 0.4 g agarose in 
25 ml DEPC-treated water. After cooUng to 60°C, 5X formaldehyde 
gel-running buffer (O.lM MOPS, pH7.0, 40mM sodium acetate, 
5mM EDTA, pH8.0) and formaldehyde was added to give final 
concentrations of IX and 2.2M, respectively. The gel was cast in a 
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chemical hood, and aUowed to set for 30 minutes at room 
temperature. 
The sample was prepared by mixing the foUowing reagents: 
4.5pl RNA (up to 30^g), 2.0pI 5X formaldehyde gel-running buffer, 
3.5pl formaldehyde, lOpI formamide. The sample was heated at 
65�C for 10 minutes and then chiUed on ice. 2^ 1 of sterile, DEPC-
txeated formaldehyde gel-loading buffer (50% glycerol, lmM EDTA, 
pH8.0, 0.25% bromophenol blue, ethidium bromide (0.5mg/ml in 
O.lM ammonium acetate) was added to the sample just before 
loading into the weU of the gel. The gel was run in IX 
formaldehyde gel-running buffer at 3 - 4 V/cm. 
The formaldehyde gel was soaked in sterile double distiUed 
water for 10 minutes with gentle shaking for 4 times. Then, the gel 
was placed in 20X SSC with gentle shaking for 10 minutes for 4 
times. A piece of Whatman 3MM filter paper was laid around a 
gkiss plate to form a support that was longer and wider than the 
gel. The wrapped support was placed inside a large baking dish. 
The dish was fiUed with transfer buffer, 20X DEPC treated SSC 
(3.0M NaCl, 3.2M sodium citrate, pH7.0) until the level of the 
Uquid reached aknost to the top of the support. When the 3MM 
paper on the top ofthe support was thoroughly wet, aU air bubbles 
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were smoothed out with a glass rod. A piece of new PVDF 
membrane (MiULpore) was cut, about 1mm krger than the gel in 
both dimensions. The membrane was pre-wetted with absolute 
ethanol and then rinsed with double distiUed water. The 
membrane was then soaked with transfer buffer (lOX SSC) for 20 
minutes. The gel was removed from the neutraUzation solution. 
The gel was inverted so that its underside was now uppermost. 
The inverted gel was pkiced on the support so that it was centered 
on the wet 3MM papers. AU the bubbles between the 3MM paper 
and the gel were removed. The gel was surrounded with Saran 
Warp to prevent any liquid from moving directiy from the reservoir 
to the paper towels pkiced on top of the gel or else it would short 
circuit. The wet PVDF membrane was placed on top of the gel so 
that the cut comers were aUgned. Two pieces of 3MM paper, the 
same size as the gel, pre-wetted with 2X SSC, were placed on top 
of the wet membrane. A stack of paper towels (5 - 8 cm high) just 
smaUer than the 3MM papers was put on the 3MM papers. A 
gkiss plate together with a 500-g weight was placed on top of the 
stack. The transfer of RNA was aUowed to proceed for 8 - 24 
hours. The RNA would be transferred onto a PVDF membrane 
(Immobilon™-N from MiUipore) by capfflary action. Before the 
membrane was removed, the positions of weUs were marked onto 
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the membrane by using a penciL The membrane was soaked in 
6X SSC for 5 minutes at room temperature to remove any pieces 
of agarose sticking to the membrane. The membrane was aUowed 
to dry on paper towels for at least 30 minutes. The RNA on the 
membrane was then fixed by exposing to iUtraviolet irradiation 
(254nm) for 2 minutes or baking at 80�C for 2 hour. The 
membrane was stored at room temperature until hybridization 
was performed. 
2.16.3 Prehybridization ofthe Northem blot 
The prepared membranes were put into a plastic box with 
each membrane separated by a wire mesh. Prehybridization buffer 
[50% formamide, 6X SSC, 5X Denhardt's solution {lOX Denhardt's 
solution stock: 0.2% bovine serum albumin (Fraction V，Sigma), 
0.2% FicoU (Type 400, Sigma), 0.2% polyvinylpyrroMone 
(Molecular Biology Reagent, Sigma)}, lOOmg/ml denatured sahnon 
sperm DNA (Sigma) (or denatured catf thymus DNA), 0.5% SDS] 
was added until the membranes were completely immersed. The 
contents were shaken ovemight at 42^C. 
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2.16.4 Hybridization ofthe Northem blot 
On the next day, the prehybridization buffer was discarded 
and replaced by freshly prepared hybridization buffer [50% 
formamide, 6X SSC, lOOmg/ml denatured salmon sperm DNA 
(Sigma) (or denatured catf thymus DNA), 0.5% SDS]. The 
radiokibeUed probe prepared in section 2.13 was denatured by 
heating at 100°C for 5 minutes. The denatured probe was added 
into the hybridization mixture immediately. The contents were 
shaken again at 42°C overnight. To reduce any background signal, 
the membrane was first washed with IX SSC (0.75M NaCl, 
0.075M trisodium citxate)/0.1% SDS at room temperature for 10 -
20 minutes. The membrane was then washed with 0.2X 
SSC/0.1% SDS at room temperature for about 10 minutes until a 
constant reading was obtained from a portable GM-counter. The 
membrane was aUowed to dry on a sheet of 3MM paper at room 
temperature. Orientation of the membrane was made with 
radioactive ink containing 32p. The filters were fixed on a sheet of 
3MM paper with adhesives. The 3MM paper was wrapped with 
ding fflm. The kibeUed signal was exposed to X-ray fQm in a 
cassette at -70°C. The fflm was developed using a developer (Kquid 
X-ray developer, T^pe 2, Kodak, Cat. No. 4051298) and fixing 
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solutions (Uquid X-ray fixer and replenisher, Kodak, Cat. No. 
4051611). 
2.17 First strand cDNA synthesis (Pharmacia) 
RNA samples in appropriate concentrations (l-5Mg/20^I) 
were prepared by dissolving in RNase free water provided by the 
kit. The RNA was denatured at 65°C for 10 minutes and chiUed on 
ice immediately. Eleven milliliters of Bvdk First-Strand Reaction 
Mix (Murine Reverse Transcriptase, RNAguard, RNase/DNase Free 
BSA, dATP, dCTP, dGTP and dTTP, in aqueous buffer), 1^ 1 of DDT 
solution and 1^ 1 of Not I-d(T)is primer (provide by the kit) were 
added into the denatured RNA. The reaction mixture was 
incubated at 3 7 � � f o r an hour. The first-strand cDNA product was 
then ready for immediate second-strand cDNA synthesis of PCR 
ampMcation. 
2.18 PCR ofthe first strand cDNA 
PCR was performed using the ampUmers C095-ATG and 
dT (Appendix), and the first strand cDNA as the template. In the 
50^1 PCR mixture, there were l^ il of the first strand cDNA, 
2.5 i^M of each of the ampKmers, 5^ il 10X reaction buffer 
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(Pharmacia), 0.5^1 Taq polymerase (2.5U/^il, Pharmacia), 5 i^l 
2mM dNTP (Pharmacia) and double distiUed water. The 
temperature profile was as foUows: 
1. 94X 5 min. 
2. 94�C 36 sec. 
3. 50�C 36 sec. 
4. 72^C 1 min. 28 sec. 
5. 72�C 10 min. 





3.1 Partial sequencing of adult human heart cDNA clones 
After the completion of the cycle sequencing reactions the 
four sequencing mixtures were electxophoresed by using the 
automated DNA sequencer (A.L.F. automated sequencer, 
PharmaciaTM) for six hours. A sample result of a processed 
electrophoresis run was shown in figure 3.1. The processed 
DNA sequences was searched for homology with other DNA 
sequences deposited in the Genbank and EMBL databases by 
using the program BLASTN (Altschul et al, 1990). The ALF ffles 
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3.2 DNA homology searching by using the program BLASTN 
The processed DNA sequences were sent in the form of 
electronic mails to the NCBI for homology searches using the 
program BLASTN. The electronic mailing address and the 
parameter settings were as below. 
To: Blast@ncbi.nhn.nih.gov 




>Name of DNA sequence 
ACGT (DNA sequence) 
The results of the homology search were then edited and 
printed (Figure 3.2). The mail sending and receiving procedures 
were accelerated by using the programs sendmail.exe and 





Sequences producing High-scoring Segment Pairs: Score P(N) N 
emb|X52967|HSRPL7 Human mRNA for ribosomal protein L7 1537 3.7e-158 3 
embIX57959|HSRBPRL7A H.sapiens mRNA for ribosomal protei... 1528 2.1e-157 3 
gb|L16558|HUMRPL7Y Human ribosomal protein L7 (RPL7) m... 1528 2.1e-157 3 
emb|X57 958|HSRBPRL7B H.sapiens mRNA for ribosomal protei... 1510 6.2e-156 3 
gb|M85235|MUSRP Mus musculus ribosomal protein mRNA... 1275 1.3e-121 2 
embIX57 9611MRBPRL7B M.musculus mRNA for ribosomal prote... 1248 5.3e-120 2 
embIX57960|MMRBPRL7A M.musculus mRNA for ribosomal prote... 1248 2.5e-118 2 
gb1M29015|MUSRPL7A Mouse ribosomal protein L7 (rpL7) g... 831 9.8e-112 3 
gb|M17 4 22|RATRPL7 Rat ribosomal protein L7 mRNA, 5' end. 1141 1.9e-108 2 
gbIM2 9016|MUSRPL7R Mouse ribosomal protein L7 (rpL7) m... 908 3.9e-90 2 
emb|X14 909|DDRPL7 Dictyolstelium discoideum mRNA for … 564 2.1e-37 1 
embIX549831SPRPL7G S. pombe rpl7 gene for ribosomal pr... 452 5.0e-31 2 
embIX69673|SPPOLAL S.pombe polAgene for DNA polymeras... 443 2.2e-29 2 
dbjID30016|RICEN25124 Rice mRNA EN251, partial sequence. 277 8.5e-25 2 
embIX15109|DMRPHOM D.melanogaster mRNA fragment for ri... 315 2.9e-23 2 
gblM2 9017 1MUSRPL718 Mouse ribosomal protein L7-18 (rpL7... 299 3.1e-15 1 
gblU35072|HSU35072 Human chromosome X YAC 878a5 cosmid... 253 6.0e-ll 1 
gb|I08513| Sequence 7 from Patent WO 8702060 225 1.2e-08 1 
emb|X06168|BSTERC Bacillus subtilis DNA for replicati... 131 0.63 1 
dbjID2 9662|MNSVNH Melon necrotic spot virus RNA for c... 126 0.92 1 
emb|Z68214|CEClOC5 Caenorhabditis elegans cosmid C10C5 123 0.992 1 
dbjID00562|MNSCP Melon necrotic spot virus, coat pro... 121 0.999 1 
dbjID12536|D12536 Melon necrotic spot virus genomic R... 121 0.9992 1 
gb|M2 9671|MNSCG Melon necrotic spot virus (clones p... 121 0.9992 1 
emb|X52967|HSRPL7 Human mRNA for ribosomal protein L7 
Length = 825 
Minus Strand HSPs: 
Score = 1537 (424.7 bits). Expect = 3.7e-158, Sum P(3) = 3.7e-158 
Identities = 317/329 (96%), Positives = 317/329 (96%), Strand = Minus / Plus 
Query: 329 GGGGGCCCCAATCTGAAGTCAGTAAATGAACTAATCTTCAAGCGTGGTTATGGCAAAATC 270 
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I 
Sbj ct � 448 GGGTACCCCAATCTGAAGTCAGTAAATGAACTAATCTACAAGCGTGGTTATGGCAAAATC 507 
Query: 269 AATAAGAAGCGAATTGCTTTGACAAATAACGCTTTGATTGCTCGATCTCTTGGTAAATAC 210 
I I I 1 I I I 1 I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I 
Sbj ct: 508 AATAAGAAGCGAATTGCTTTGACAGATAACGCTTTGATTGCTCGATCTCTTGGTAAATAC 567 
Query : 209 GGCATCATCTGCATGGAGAATTTGATTCATGAGATCTATACTGTTGGAAAACGCTTCAAA 150 
I I 1 I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I 
Sbj ct � 568 GGCATCATCTGCATGGAGGATTTGATTCATGAGATCTATACTGTTGGAAAACGCTTCAAA 627 
Query 149 GAGGCAAATAACTTCCTGTGGCCCTTCAAATTGTCTTCCTCACGAGGTGGAATGAAGAAA 90 
‘ I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I 
Sbj ct: 628 GAGGCAAATAACTTCCTGTGGCCCTTCAAATTGTCTTCTCCACGAGGTGGAATGAAGAAA 687 
Query 89 AAGACCACCCATTTTGAAGAAGGTGGAGATGCTGGAAACAGGAAAAACCAGATCAACAGG 30 
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I 
Sbj c t � 688 AAGACCACCCATTTTGTAGAAGGTGGAGATGCTGGCAACAGGGAGGACCAGATCAACAGG 747 
Query: 29 CTTATTAGAAGAATGAACTAAGGTGTCTA 1 
I I I I I I I I I I I I I I I I I I I I I I I I I i I I I Sbj ct: 748 CTTATTAGAAGAATGAACTAAGGTGTCTA 77 6 
Figure 3.2 A sample result of an edited DNA homology search 
by using the program BLASTN. 
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3.2.1 Catalogue of the 502 BSTs of the cardiovascular 
system 
The results of the DNA homology search of the 502 cDNA 
clones were summarized and stored in a database (Lopez et al, 
1992) including clone name, identity, accession number, 
sequence length of the cDNA and the percentage of homology 
with other DNA sequences (Table 3.1). 
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Table 3.1 A catalogue of the 502 adult human heart cDNA clones. 
Clone Putative identity Accession Length %match 
G775-F Alu repeat 255 
H561-F Alu repeat 153 
H217-F Alu repeat 271 
G917-F Alu repeat 224 
G940-F Alu repeat 192 
H445-F Alu repeat 236 
H044-F Alu repeat 237 
H546-F Alu repeat 162 
G884-F Alu repeat 252 
H404-F Alu repeat 150 
G865-F Alu repeat 150 
G591-F Alu repeat 152 
H595-F Alu repeat 301 
G590-F Alu repeat 245 
H140-F Alu repeat 229 
H337-F Alu repeat 347 
G819-F Alu repeat 248 
H534-F Alu repeat 224 
H426-F Alu repeat 324 
H180-F Alu repeat 224 
H549-F Alu repeat 172 
H031-F Alu repeat 249 
H354-F Alu repeat 435 
H261-F Alu repeat 202 
H389-F Alu repeat 161 
H192-F Alu repeat 317 
H348-F Alu repeat 308 
H218-F Alu repeat 208 
G453-F Alu repeat 304 
G887-F Alu repeat 357 
H569-F Alu repeat 160 
H638-F Alu repeat 330 
G962-F Alu repeat 182 
G686-F Alu repeat 173 
H247-F Alu repeat 170 
G675-F Alu repeat 400 
• H273-F AIu repeat 154 
G785-F Alu repeat 332 
G658-F Canis familiaris adenylyl cyclase gb|M94968| 150 82 
type VI 
H533-F Cow cathepsin B gb|L06075| 154 80 
G934-F Cow ubiquinone oxidoreductase gb|X63211| 153 88 
H587-F Human DNA binding protein B gb|M24070| 190 98 
H459-F Human DNF1552 gb|J03068| 150 94 
G791-F Human Hl9 RNA gb|M32053| 215 97 
G469-F Human ORF gb|D26068| 150 58 
G646-F Human Ro ribonucleoprotein autoantigen gb|M32294| 224 100 
G685-F Human Ro ribonucleoprotein autoantigen gb|M32294| 254 98 
H457-F Human S-adenosylhomocysteine hydrolase gb|M61831| 251 100 
G458-F Human U6 snRNA gb|X593621 403 94 
G529-F Human acidic ribosomal phosphoprotein P0gb|M17885| 362 97 
H116-F Human actin, alpha cardiac gb|J00073| 150 94 
G592_F Human actin, alpha-cardiac gb|J00072| 194 92 
H049-F Human actin, cardiac alpha gb|M10652| 150 94 
H254-F Human actin, cardiac-alpha gb|M10652| 317 94 
H555_F Human actin, gamma gb|S578131 159 93 
H583-F Human actin, gamma pseudogene gb|M37130| 162 97 
G853_F Human actin-binding protein gb|X53416| 150 94 
H629_F Human aldolase A gb|M11560| 205 95 
G928_F Human aldolase A, fibroblast gb|X05236| 150 76 
H425-F Human aldolase A, fibroblast emb|X05236| 207 100 
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H565-F Human aldolase A, fibroblast emb|X05236| 196 95 
H572-F Human aldolase C gb|X07292| 284 96 
H339-F Human alpha palindromic binding protein gb|U02683| 150 96 
G434-F Human anonymous gene gb|Ll89721 158 95 
H248-F Human beta-amyloid A4 gb|M18734| 293 98 
H458-F Human beta-enolase gb|X16504| 197 97 
H138-F Human beta-myosin heavy chain gb|X51591| 270 91 
H449-F Human beta-tubulin gb|V00599| 311 98 
H658-F Human binding protein gb|Ll9597| 204 100 
H548-F Human binding protein gb|L19597| 162 98 
H308-F Human calmodulin gb|M78211| 168 92 
H118-F Human cardiodilation atrial gb|M30262| 150 92 
natriuretic peptide 
H160-F Human cardiodilation-atrial gb|M30262| 334 97 
nariuretic factor 
G615-F Human chloride channel gb|Z30643| 214 93 
H319-F Human cholesterol 7-alpha hydroxylase gb|L07951| 341 90 
G537-F Human collagen type I alpha-1 gb|X55525| 396 98 
H578-F Human collagen type I pro-alpha-1 gb|K01228| 150 76 
H025_F Human collagen type I pro-alpha-1 gb|X06269| 351 98 
G465_F Human collagen type I pro-alpha-1 gb|X06269| 302 96 
H334-F Human collagen type III pro-alpha-1 gb|X14420| 150 98 
G921-F Human collagen type IV alpha gb|X05610| 150 69 
G780-F Human collagen type IV alpha-2 emb|X05610| 339 100 
H269-F Human collagen type IV alpha-2 gb|X05610| 150 92 
H095-F Human collagen type alpha-2 gb|X55525| 162 96 
G875_F Human cyclin gb|M74091| 215 97 
H271-F Human elastin gb|M17282| 150 83 
H331_F Human elongation factor 1-alpha gb|M29548| 324 100 
H281-F Human elongation factor 1-alpha gb|M29548| 199 91 
G719-F Human elongation factor 1-alpha gb|M29548| 150 87 
G758-F Human glucose-6-phosphate dehydrogenase gb|A17975| 150 84 
H216-F Human heat shock protein 27 gb|X54079| 186 97 
G647-F Human heat shock protein 40 gb|M79244| 180 96 
G807-F Human insulin-like growth factor 5 gb|M62403| 188 100 
binding protein 
G765_F Human laminin receptor homolog gb|S35960| 15 6 100 
G760_F Human laminin receptor, lung gb|S37431| 150 96 
G832-F Human medium tumor antigen-associated gb|M31786| 150 85 
protein 
H285-F Human mitochondrial genome gb|X62996| 260 99 
G683-F Human mitochondrial genome gb|X62996| 318 91 
G526-F Human mitochondrial genome gb|X629961 345 91 
G679-F Human mitochondrial genome gb|X62996| 188 94 
G532-F Human mitochondrial genome gb|X62996| 18 6 93 
G711-F Human mitochondrial genome gb|X62996| 208 100 
H601-F Human mitochondrial genome gb|X62996| 252 96 
H256_F Human mitochondrial genome gb|X62996| 150 84 
. H593-F Human mitochondrial genome emb|V00662| 151 88 
G503-F Human mitochondrial genome gb|X62996| 226 97 
G772_F Human mitochondrial genome gb|X62996| 261 
H641-F Human mitochondrial genome gb|X62996| 199 99 
H188_F Human mitochondrial genome gb|X62996| 172 98 
G766_F Human mitochondrial genome gb|X62996| 150 96 
G514_F Human mitochondrial genome gb|X62996| 257 9S 
H144-F Human mitochondrial genome gb|X62996| 167 99 
G891-F Human mitochondrial genome gb|X62996| 150 98 
H485_F Human mitochondrial genome gb|X62996| 203 95 
H411_F Human mitochondrial genome gb|X62996| 234 92 
G804_F Human mitochondrial genome gb|X62996| 306 98 
G614-F Human mitochondrial genome gb|X62996| 328 9Q 
G737_F Human mitochondrial genome gb|X62996| 181 ^0 
H323_F Human mitochondrial genome gb|X62^S^| 220 ^4 
H163-F Human mitochondrial genome ^ ^ ' ^ � � ! }l^ ll 
G792-F Human mitochondrial genome 9b|X62996 184 96 
H300_F Human mitochondrial genome gh\X629^b\ zzz �� 
H089-F Human mitochondrial genome ^ $"996 150 ^6 
H650-F Human mitochondrial genome g ^ ^ = l 311 ^^ 
H625-F Human mitochondrial genome ^^^"996 160 � 
G769-F Human mitochondrial genome 9b X62996 150 9^ 
G878-F Human mitochondrial genome ^b X62996 207 ^ 0 
G455-F Human mitochondrial genome gb|X62996| 200 94 
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G694-F Human mitochondrial genome gb|X62996| 150 98 
H661-F Human mitochondrial genome gb|X62996| 150 97 
H215-F Human mitochondrial genome gb|X62996| 150 98 
G864-F Human mitochondrial genome gb|X62996| 281 98 
G857-F Human mitochondrial genome gb|X62996| 283 91 
G863-F Human mitochondrial genome gb|X62996| 200 100 
H648-F Human mitochondrial genome gb|62996| 362 98 
H303-F Human mitochondrial genome gb|X62996| 150 89 
G565-F Human mitochondrial genome gb|X62996| 153 100 
H321-F Human mitochondrial genome gb|X62996| 220 98 
H365-F Human mitochondrial genome gb|X62996| 347 97 
H442-F Human mitochondrial genome gb|X62996| 223 98 
G689-F Human mitochondrial genome gb|X62996| 233 98 
G881-F Human mitochondrial genome gb|X62996| 243 100 
H493-F Human mitochondrial genome gb|X62996| 170 96 
H175-F Human mitochondrial genome gb|X62996| 293 98 
G704-F Human mitochondrial genome gb|X62996| 167 97 
H366-F Human mitochondrial genome gb|X62996| 178 92 
H298-F Human mitochondrial genome gb|X62996| 182 96 
H460-F Human mitochondrial genome gb|X62996| 250 92 
G779-F Human murine sarcoma 3611 viral 1 gb|L240381 221 94 
oncogene homolog 
H329-F Human myosin heavy chain, alpha gb|M21664| 379 97 
G555-F Human myosin heavy chain, beta gb|M58018| 152 96 
G997-F Human myosin heavy chain, beta gb|X51591| 363 96 
G894-F Human myosin heavy chain, beta gb|M58018| 156 91 
G876-F Human myosin heavy chain, cardiac beta gb|M25137| 150 97 
H310-F Human myosin heavy chain, cardiac-beta gb|M25137| 322 85 
H637-F Human myosin light chain, 20 kDa gb|J02854| 209 93 
H427-F Human myosin light chain, embryonic gb|M37075| 303 88 
G522-F Human natural killer cell enhancer gb|L19185| 241 96 
factor 
G911-F Human novel protein AHNAK gb|M80899| 186 96 
G899-F Human nuclear pore complex protein gb|Z25535| 294 98 
G802-F Human nucleic acid binding protein gb|L12 693| 261 98 
H550_F Human nucleosome assembly protein gb|M86667| 150 100 
G665-F Human partial cDNA sequence gb|D13627| 150 80 
G778-F Human partial cDNA sequence gb|Z13853| 289 96 
G634-F Human partial cDNA sequence gb|T08448| 230 97 
G633-F Human partial cDNA sequence gb|Z16361| 300 96 
G548-F Human partial cDNA sequence gb|Z15771| 170 92 
G4 62-F Human partial cDNA sequence gb|T06399| 475 96 
G798-F Human partial cDNA sequence gb|Z13204| 290 98 
G822_F Human partial cDNA sequence gb|T09008| 361 100 
G859-F Human partial cDNA sequence gb|M79252| 259 96 
G858_F Human partial cDNA sequence gb|T08545| 150 97 
G741-F Human partial cDNA sequence gb|Z13748| 150 90 
G890-F Human partial cDNA sequence gb|Z20579| 318 87 
. G924-F Human partial cDNA sequence gb|Z15328| 336 98 
H590-F Human partial cDNA sequence emb|Z13388| 180 89 
G618-F Human partial cDNA sequence gb|Z16322| 169 91 
G793-F Human partial cDNA sequence gb|Z16322| 221 86 
G567-F Human partial cDNA sequence gb|D11655| 200 92 
G708_F Human partial cDNA sequence gb|Z13721| 190 98 
G800-F Human partial cDNA sequence gb|D13643| 163 97 
G693_F Human partial cDNA sequence gb|Z13492| 190 94 
G880_F Human partial cDNA sequence gb|T08672| 150 96 
G457_F Human partial cDNA sequence gb|Z12704| 204 98 
G631-F Human partial cDNA sequence gb|Z13357| 357 98 
H076-F Human partial cDNA sequence gb|Z15888| 301 97 
H316-F Human partial cDNA sequence gb|Z16322| 199 100 
H102-F Human partial cDNA sequence gb|Z18314| 164 98 
H560_F Human partial cDNA sequence gb|Z15253| 210 95 
H166_F Human partial cDNA sequence gb|D25943| 343 100 
H580-F Human partial cDNA sequence emb|Z156141 230 99 
H194-F Human partial cDNA sequence gb|Z15853| 362 93 
H487-F Human partial cDNA sequence gb|Z13207| 228 89 
G975-F Human partial cDNA sequence gb|Z15460| 163 
H189_F Human partial cDNA sequence emb|Z12931| 229 95 
H470-F Human partial cDNA sequence ^^'^i!!3!! ltt ? L Hlll-F Human partial cDNA sequence gb|M78843| 150 ^"" H659-F Human partial cDNA sequence gb|Z16004| 159 95 
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H082-F Human partial cDNA sequence gb|T24098| 158 96 
H402-F Human partial cDNA sequence gb|Z13839| 160 96 
H343-F Human partial cDNA sequence gb|Zl6031| 309 97 
H139-F Human partial cDNA sequence gb|Z16204| 241 97 
H183-F Human partial cDNA sequence gb|Z15278| 150 85 
H324-F Human partial cDNA sequence gb|M85815| 169 99 
H318-F Human partial cDNA sequence gb|Z15753| 240 96 
H162-F Human partial cDNA sequence gb|Z24817| 150 81 
H164-F Human partial cDNA sequence gb|Z12892| 169 67 
H510-F Human partial cDNA sequence gb|D31883| 162 96 
H115-F Human partial cDNA sequence gb|D20156| 302 90 
H313-F Human partial cDNA sequence gb|T16731| 230 94 
H358-F Human partial cDNA sequence gb|Zl3097| 150 95 
H255-F Human partial cDNA sequence gb|Zl6361| 193 98 
H327-F Human partial cDNA sequence gb|Z13428| 404 95 
H479-F Human partial cDNA sequence gb|Z13097| 284 99 
H311-F Human partial cDNA sequence gb|D19705| 192 98 
H226-F Human partial cDNA sequence gb|Z13873| 150 87 
G971-F Human partial cDNA sequence gb|Z13226| 243 68 
H177-F Human partial cDNA sequence gb|Z15278| 447 97 
H170-F Human partial cDNA sequence gb|Z15218| 259 100 
G966-F Human partial cDNA sequence gb|Z16361| 177 98 
G972-F Human partial cDNA sequence gb|Zl6205| 211 98 
H168-F Human partial cDNAs equence gb|T08842| 327 95 
G767-F Human peroxisomal 3-oxacyl-CoA emb|X65145| 150 98 
thiolase 
H505-F Human phosphoglycerate mutase gb|J04173| 353 98 
type B subunit 
G959-F Human placental protein 14 gb|M34046| 311 81 
G516-F Human presumptive KDEL receptor gb|X55885| 150 100 
H368_F Human procollagen type I pro-alpha-2 gb|V00503| 150 96 
G712-F Human pyruvate dehydrogenase El-beta gb|M3405 6| 250 99 
subunit 
H317-F Human pyruvate dehydrogenase El-beta gb|M34056| 150 97 
subunit 
H267-F Human receptor of retinoic acid gb|X06614| 178 79 
G585-F Human ribosomal RNA gb|M11167| 150 96 
H178-F Human ribosomal protein Lll homologue gb|L05092| 205 92 
G970-F Human ribosomal protein L18 gb|L11566| 241 93 
H087-F Human ribosomal protein L3 gb|M90054| 260 98 
G629-F Human ribosomal protein L7 gb|X52967| 422 96 
H463-F Human ribosomal protein L8 emb|Z284071 164 88 
H506-F Human ribosomal protein S20 gb|D11781| 159 91 
G749-F Human ribosomal protein S3 gb|S426581 150 99 
H244-F Human ribosomal protein S8 gb|X67247| 150 98 
G680-F Human rod outer segment membrane gb|M96759| 403 68 
protein 1 
H023-F Human secretogranin I gb|Y00064| 236 95 
H598-F Human skeletal muscle 190 kDa protein gb|X69090| 310 99 
H094-F Human small nuclear ribonucleoprotein gb|M57937| 152 84 
H530-F Human small nuclear ribonucleoprotein gb|J04615| 248 91 
SM-D 
H320_F Human steroid sulfatase gb|Ml6505| 230 85 
G892-F Human thyroid autoantigen gb|J04 607| 178 97 
H649-F Human translationally controlled gb|X16064| 150 97 
tumor protein 
H401-F Human tropomyosin, fibroblast gb|X05276| 200 100 
H482-F Human tropomyosin, skeletal alpha gb|M19714| 195 97 
H489-F Human troponin I, slow-twitch skeletal gb|J04760| 175 96 
H469-F Human troponin T, cardiac gb|S64668| 336 97 
G716_F Human tubulin beta-pseudogene gb|K00841| 186 80 
H642-F Human tubulin, beta gb|J00314| 170 95 
G773-F Human tubulin, beta gb|X02344| 162 9A 
G950-F Human ubiquitin-conjugated enzyme gb|Z29328| 169 95 
G861_F Human vitamin D-binding protein gb|L10641| 150 SB 
G475_F Mouse MUCl8 glycoprotein gb|X74628| 293 92 
H644-F Mouse P311 gb|X70398| 348 98 
H122-F Mouse RNA binding protein gb|Ll7076| 360 ^9 
G710_F Mouse capping protein beta-subunit gb|U10407| 150 11 
G464-F Mouse capping protein beta-subunit gb|U10407| 321 90 
H657-F Mouse malate dehydrogenase g ^ ^ ^ g ! � � � 
H433-F Mouse oncofetal antigen gb|U06662| 301 98 
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G967-F Mouse partial cDNA sequence gb|Z21484| 208 92 
H305-F Mouse partial cDNA sequence gb|D16262| 150 92 
G645-F Mouse reticulocalbin gb|Dl3003| 197 62 
G705-F Mouse skelemin gb|Z22866| 155 93 
G744-F Novel 150 
H210-F Novel 150 
H184-F Novel 150 
H042-F Novel 250 
G903-F Novel 150 
H038-F Novel 150 
H172-F Novel 214 
H211-F Novel 150 
G751-F Novel 245 
H186-F Novel 150 
G740-F Novel 154 
G728-F Novel 150 
G900-F Novel 247 
H187-F Novel 175 
H191-F Novel 191 
G803-F Novel 322 
G698-F Novel 233 
H193-F Novel 270 
G684-F Novel 360 
H195-F Novel 270 
H088-F Novel 240 
H026-F Novel 319 
H022-F Novel 150 
H169-F Novel 351 
G678-F Novel 217 
H219-F Novel 213 
H257-F Novel 215 
H222-F Novel 165 
H259-F Novel 237 
H242-F Novel 1^0 
H200-F Novel 302 
G885-F Novel 175 
H264-F Novel 150 
G713-F Novel 174 
H265-F Novel 150 
G692-F Novel 150 
H014-F Novel 229 
H241-F Novel 150 
H229-F Novel 155 
H203-F Novel 274 
H220-F Novel 150 
H079-F Novel 354 
H058-F Novel 243 
G886-F Novel 159 
‘ G811-F Novel 200 
H246-F Novel 150 
H328-F Novel ^ � 
G914-F Novel 218 
H351-F Novel 15° 
H276-F Novel ^^^ 
G888-F Novel ^®° 
H282-F Novel ^20 
G920-F Novel |^° 
G840-F Novel 183 
H378-F Novel ^^J 
H050-F Novel j^° 
H356-F Novel |^° 
H283-F Novel jj° 
H380-F Novel }^^ 
H275-F Novel }'° 
H363-F Novel }®° 
H344-F Novel � 
G628-F Novel � 
H161-F Novel f^f 
H204-F Novel ^®^ 
G677-F Novel � 
H045-F Novel � 
H156-F Novel “ � 
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H153-F Novel 150 
G696-F Novel 189 
H386-F Novel 285 
H325-F Novel 259 
G650-F Novel 150 
G697-F Novel 167 
H393-F Novel 332 
G670-F Novel 228 
H398-F Novel 172 
H431-F Novel 340 
G821-F Novel 150 
G635-F Novel 244 
G632-F Novel 258 
G709-F Novel 150 
H430-F Novel 343 
G842-F Novel 150 
H434-F Novel 250 
H335-F Novel 218 
G643-F Novel 150 
H104-F Novel 280 
H415-F Novel 159 
G653-F Novel 150 
H439-F Novel 180 
H424-F Novel 270 
H440-F Novel 320 
H429-F Novel 210 
H299-F Novel 158 
G895-F Novel 259 
H346-F Novel 349 
G830-F Novel 150 
H301-F Novel 293 
G659-F Novel 1^1 
H437-F Novel 255 
G958-F Novel 1^0 
H332-F Novel 170 
H315-F Novel 321 
G636-F Novel 312 
G817-F Novel 150 
H454-F Novel 249 
H447-F Novel 272 
G603-F Novel 204 
H333-F Novel 150 
G617-F Novel 167 
G539-F Novel 176 
H077-F Novel � ° 
H155-F Novel ^81 
H126-F Novel � 
H514-F Novel ^^^ 
G538-F Novel �� 
H513-F Novel i^° 
G534-F Novel � ^ ° 
H306-F Novel ^ " 
H124-F Novel ^°" 
H655-F Novel � ° ® 
H123-F Novel f®^ 
H639-F Novel � 
H121-F Novel �� 
H541-F Novel g $ 
G473-F Novel f^^ 
H307-F Novel � 
G468-F Novel � 
H653-F Novel � 
G868-F Novel � 
H610-F Novel � 
G520-F Novel t^^ 
H503-F Novel � 
G518-F Novel � 
H504-F Novel � 
G948-F Novel 
H630-F Novel 




G854-F Novel 215 
H646-F Novel 153 
G515-F Novel 310 
H614-F Novel 160 
H096-F Novel 156 
H604-F Novel 300 
H113-F Novel 254 
H577-F Novel 279 
G946-F Novel 165 
H640-F Novel 164 
H103-F Novel 205 
H634-F Novel 150 
H472-F Novel 210 
H596-F Novel 200 
G456-F Novel 205 
H570-F Novel 259 
H455-F Novel 180 
H592-F Novel 189 
H444-F Novel 256 
H564-F Novel 416 
G944-F Novel 159 
H568-F Novel 1^0 
G956-F Novel 257 
H477-F Novel 157 
H304-F Novel 186 
H312-F Novel 240 
G452-F Novel 225 
H631-F Novel 178 
H2 68-F Novel 174 
H516-F Novel 203 
H517-F Novel 190 
H623-F Novel 15^ 
G848-F Novel 204 
H523-F Novel 207 
G846-F Novel ^^^ 
H599-F Novel 1®0 
G768-F Novel ^^^ 
H502-F Novel 206 
H100-F Novel 18^ 
H647-F Novel 1^4 
G622-F Novel 181 
H557-F Novel ^^° 
G561-F Novel � g 
H582-F Novel ” g 
G540-F Novel � 
H524-F Novel � 
G641-F Novel j^° 
. H528-F Novel \l^ 
G602-F Novel � ^ � 
H544-F Novel � 
H205-F Novel � 
H553-F Novel � 
H450-F Novel � 
H554-F Novel ^ � " 
G608-F Novel � = 
H484-F Novel � 
H043-F Novel ^^^ 
G541-F Novel � 
G613-F Novel � 
G642-F Novel � 
H129-F Novel � 
G973-F Novel � 
G549-F Novel � 
G451-F Novel � 
H003-F Novel ^^ 
G437-F Novel 
G787-F Novel ^ 
H274-F Novel • 
H466-F Novel 258 
H106-F Novel 口工 




H086-F Novel 150 
H355-F Novel 160 
G597-F Novel 150 
G922-F Novel 397 
G616-F Novel 288 
H001-F Novel ISO 
H167-F Novel 345 
G873-F Pig heart aconitase gb|J05224| 187 90 
H110-F Rat 14-3-3 protein gamma-subtype gb|D17447| 159 79 
G889-F Rat cytoplasmic dynein heavy chain gb|D13896| 150 86 
H347-F Rat drosophila polarity gene gb|L02529| 166 92 
H148-F Rat minimal change nephritis gb|L07318| 150 98 
transmembrane protein 
H146-F Rat preproenkephalin gb|X59136| 152 90 
H330-F Rat ribosomal protein L29 gb|X68283| 224 86 
G476-F Rat wistar peroxisomal enoyl gb|U08976| 252 69 
hydratase-like protein 
H435-F Repetitive sequence 172 
H448-F Repetitive sequence 257 
G925-F Repetitive sequence 286 
H471-F Repetitive sequence 337 
H547-F Repetitive sequence 155 
H643-F Repetitive sequence 256 
H636-F Repetitive sequence 212 
H508-F Repetitive sequence 150 
G4 63-F Repetitive sequence 386 
G977-F Repetitive sequence 175 
H053-F Repetitive sequence 192 
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3.2.2 Classification and frequency of the human adult heart 
cDNA clones 
The 502 human adult heart cDNA sequences could be 
divided into eight groups which were novel sequence, expressed 
sequence tag (EST), human match, non-human match, human 
ribosomal RNA, human mitochondrial, Alu sequence and other 
repetitive sequence. The relative frequency of each group was 
depicted in table 3.2. 
Table 3.2 Classification and frequency of the 502 human adult 
heart cDNA clones. 
7jroup I Frequency Percentage (%) 
Novel 219 43.6 
Human-match 101 20.1 
EST 60 12.0 
Human mitochondrial 52 10.4 
Alu sequence 38 7.6 
Non-human match 20 4.0 
Repetitive sequence 11 2.2 
Human ribosomal RNA 1 0^ 
Total: 502 100 
Novel: ESTs that matched with no identity. 
Human-match: ESTs that matched with the human sequences. 
EST: ESTs that matched with the now existing ESTs. 
Human mitochondrial: ESTs that matched with the human 
mitochondrial sequences. 
Alu sequence: ESTs that matched the human Alu sequences. 
Non-human match: ESTs that matched with the sequences from 
other eukaryotic organisms. 
Repetitive sequence: ESTs that matched with the human repetitive 
sequences. 




3.3 Submission of the cDNA sequences to NCBI 
219 of the novel cDNA and 60 of the ESTs (Table 3.2) that 
matched with no existent sequence and other ESTs respectively 
in the GenBank and EMBL databases were submitted to NCBI. 
The corresponding accession numbers of the deposited 
sequences were summarized in table 3.3. 
Table 3.3 dbEST_Id and GenBank accession numbers of the 
novel sequences (A) and ESTs (B) assigned by the NCBI. 
(A) 
dBEST_Id User_Id GenBank_Acc dBEST_Id User_Id GenBank_Acc 
152265 HG452-F R15598 152297 HG914-F R15630 
152266 HG456-F R15599 152298 HG922-F R15631 
152267 HG473-F R15600 152299 HG948-F R15632 
152268 HG515-F R15601 152300 HG956-F R15633 
152269 HG520-F R15602 152301 HH014-F R15634 
152270 HG534-F R15603 152302 HH026-F R15635 
152271 HG602-F R15604 152303 HH042-F R15636 
152272 HG603-F R15605 152304 HH058-F R15637 
152273 HG608-F R15606 152305 HH077-F R15638 
152274 HG616-F R15607 152306 HH079-F R15639 
152275 HG622-F R15608 152307 HH088-F R15640 
152276 HG628-F R15609 152308 HH103-F R15641 
152277 HG632-F R15610 152309 HH104-F R15642 
152278 HG635-F R15611 152310 HH113-F R15643 
152279 HG636-F R15612 152311 HH123-F R15458 
152280 HG670-F R15613 152312 HH126-F R15459 
152281 HG678-F R15614 152313 HH129-F R15460 
152282 HG684-F R15615 152314 HH153-F R15461 
152283 HG696-F R15616 152315 HH155-F R15462 
152284 HG751-F R15617 152316 HH156-F R15463 
152285 HG768-F R15618 152317 HH161-F R15464 
152286 HG787-F R15619 152318 HH167-F R15465 
152287 HG803-F R15620 152319 HH169-F R15466 
152288 HG811-F R15621 152320 HH172-F R15467 
152289 HG840-F R15622 152321 HH191-F R15468 
152290 HG848-F R15623 152322 HH193-F R15469 
152291 HG854-F R15624 152323 HH195-F R15470 
152292 HG868-F R15625 152324 HH200-F R15471 
152293 HG869-F R15626 152325 HH203-F R15472 
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152294 HG888-F R15627 152326 HH204-F R15473 
152295 HG895-F R15628 152327 HH219-F R15474 
152296 HG900-F R15629 152328 HH257-F R15475 
dBEST_Id User_Id GenBank_Acc dBEST_Id User_Id GenBank_Acc 
152329 HH259-F R15476 152350 HH454-F R15648 
152330 HH282-F R15477 152351 HH472-F R15649 
152331 HH283-F R15478 152352 HH484-F R15650 
152332 HH301-F R15479 152353 HH502-F R15651 
152333 HH304-F R15480 152354 HH503-F R15652 
152334 HH312-F R15481 152355 HH504-F R15653 
152335 HH315-F R15482 152356 HH507-F R15654 
152336 HH325-F R15483 152357 HH514-F R15655 
152337 HH328-F R15484 152358 HH516-F R15656 
152338 HH335-F R15485 152359 HH517-F R15657 
152339 HH346-F R15486 152360 HH523-F R15658 
152340 HH386-F R15487 152361 HH541-F R15659 
152341 HH393-F R15488 152362 HH564-F R15660 
152342 HH424-F R15489 152363 HH570-F R15661 
152343 HH429-F R15490 152364 HH577-F R15662 
152344 HH431-F R15491 152365 HH592-F R15663 
152345 HH434-F R15492 152366 HH596-F R15664 
152346 HH437-F R15644 152367 HH604-F R15665 
152347 HH440-F R15645 152368 HH639-F R15666 
152348 HH447-F R15646 152369 HH653-F R15667 
152349 HH450-F R15647 
(B) 
dBEST_Id User_Id GenBank_Acc dBEST_Id User_Id GenBank_Acc 
152225 HG457-F R15558 152245 HH139-F R15578 
152226 HG462-F R15559 152246 HH166-F R15579 
152227 HG567-F R15560 152247 HH168-F R15580 
152228 HG631-F R15561 152248 HH170-F R15581 
152229 HG633-F R15562 152249 HH177-F R15582 
152230 HG634-F R15563 152250 HH189-F R15583 
152231 HG693-F R15564 152251 HH194-F R15584 
152232 HG708-F R15565 152252 HH255-F R15585 
152233 HG778-F R15566 152253 HH311-F R15586 
152234 HG793-F R15567 152254 HH313-F R15587 
152235 HG798-F R15568 152255 HH316-F R15588 
152236 HG822-F R15569 152256 HH318-F R15589 
152237 HG859-F R15570 152257 HH327-F R15590 
152238 HG890-F R15571 152258 HH343-F R15591 
152239 HG924-F R15572 152259 HH470-F R15592 
152240 HG967-F R15573 152260 HH479-F R15593 
152241 HG971-F R15574 152261 HH487-F R15594 
152242 HG972-F R15575 152262 HH560-F R15595 
152243 HH076-F R15576 152263 HH580-F R15596 
152244 HH115-F R15577 152264 HH590-F R15597 
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3.4 Pattern of gene expression in the human adult 
cardiovascular system 
Out of the 502 ESTs that were sequenced, there are l01 
human matches and 20 non-human matches (Table 3.2). In 
order to study the pattem of gene expression in the human 
adult heart, human matches and non-human matches are 
categorized into eleven groups: Contractile elements, 
cytoskeleton and related proteins, extraceUular matrix proteins, 
proteins involved in energy metaboUsm, hormones and proteins 
involved in hormonal regulation, proteins that participate in 
signal transduction and ceU regulation, proteins of 
transcriptional and translational machinery, membrane 
associated proteins, heat shock proteins, proteins involved in 
other metaboUsm and misceUaneous proteins (Tables 3.4 and 
3.5). j 
The most abundant gene in the adult human heart cDNA 
Ubrary is the beta-myosin heavy chain (Liew et al, 1994). It 
represents 1.2% of aU ESTs generated in this project. The 
second is the alpha-cardiac actin (0.8%). Both of them are 
contractile elements which play important roles in the 
contraction of the cardiac muscle. 
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Table 3.4 Pattem of gene expression of human adult heart 
cDNA Ubrary. 
Category Frequency 15^ 
Contractile elements 17 14.2 
Cytoskeleton related 12 10.0 
ExtraceUular matrix 14 11.7 
Energy metaboUsm 13 10.8 
Hormones and hormonal regulation 6 5.0 
Signal transduction/ceU regulation 4 3.3 
Transcription and translation 27 22.5 
Membrane associated 7 5.8 
Heat shock protein 2 1.7 
Other metaboUsm 5 4.2 
MisceUaneous 13 10.8 � 
Total 120 100 
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Table 3.5 Human cardiac ESTs which matched to known genes 
in the GenBaak and EMBL databases. Presented are genes to 
which cardiac ESTs matched, together with accession numbers 
for these genes and number of clones from which the ESTs were 
derived. In cases where multiple clones representing a single 
gene exist, only a single, representative clone is given. In cases 
where ESTs matched to non-human sequences, the organism 
from which the matching sequence was derived is also indicated 
in parentheses. 
Gene Locus Frequency 
1) Contractile elements 
Actin, alpha-cardiac gb J00072 4 
Myosin heavy chain, cardiac alpha gb M21664 1 
Myosin heavy chain, cardiac beta gb M25137 6 
Myosin light chain, 20 kDa gb J02845 1 
Myosin light chain, embryonic gb M37075 1 
Tropomyosin, fibroblast gb X05276 1 
Tropomyosin, skeletal alpha gb M19714 1 
Troponin I, slow-twitch skeletal gb J04760 1 
Troponin T, cardiac gb S64668 1 
2) Cytoskeleton and related protein 
Actin, garnma gb S57813 1 
Actin, gamma pseudogene gb M37130 1 
Actin-binding protein gb X53416 1 
Capping protein beta-subunit (Mouse) gb U10407 2 
Cytoplasmic dynein heavy chain (Rat) gb D13896 1 
Skelemin (Mouse) gb Z22866 1 
Skeletal muscle 190kDa protein gb X69090 1 
Tubulin, beta gb <J00314 3 
Tubulin, beta pseudogene gb K00841 1 
3) Extracellular matrix 
Collagen type I alpha-1 gb X55525 1 
Collagen type I pro-alpha-1 gb X06269 3 
Collagen type III pro-alpha-1 gb X14420 1 
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Collagen type IV alpha-2 gb X05610 4 
Procollagen type I pro-alpha-2 gb V00503 1 
Elastin gb M17282 1 
Laminin receptor homolog gb S35960 1 
Laminin receptor, lung gb S37431 1 
Vitamin D-binding protein gb L10641 1 
4) Energy metabolism 
Aconitase, heart (Pig) gb J05224 1 
Aldolase A gb M11560 1 
Aldolase K, fibroblast gb X05236 3 
Aldolase C emb X07292 1 
Glucose-6-phosphate dehydrogenase gb A17975 1 
Malate dehydrogenase (Mouse) gb M29462 1 
Phosphoglycerate mutase, type B subunit gb J04173 1 
Pyruvate dehydrogenase El-beta subunit gb M34056 2 
S-adenosylhomocysteine hydrolase gb M61831 1 
Ubiquinone oxidoreductase (Cow) gb X63211 1 
5) Hormones and hormonal regulation 
Cardiodilation atrial natriuretic factor gb M30262 2 
Insulin-like growth factor binding protein 5 gb M62403 1 
Preproenkephalin (Rat) gb X59136 1 
Retinoic acid receptor gb X06614 1 
Steroid sulfatase gb M16505 1 
6) Signal transduction and cell regulation 
Adenylyl cyclase VI (Dog) gb M94968 1 
Cyclin gb M74091 1 
Gamma 14-3-3 isoform (Rat) gb Z19599 1 
Secretogranin I gb Y00064 1 
7) Transcription and translation 
Acidic ribosomal phosphoprotein P0 gb M17885 1 
A3-pha palindromic binding protein gb U02683 1 
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Binding protein gb L19597 2 
DNA binding protein B gb M24070 1 
Drosophila polarity gene (Rat) gb L02529 1 
Elongation factor 1-alpha gb M29548 3 
H19 RNA gb M32053 1 
Nucleic acid binding protein gb L19661 1 
Nucleosome assembly protein gb M86667 1 
Ribosomal protein L3 gb M90054 1 
Ribosomal protein L7 gb X52967 1 
Ribosomal protein L8 gb T07704 1 
Ribosomal protein Lll gb L05092 1 
Ribosomal protein L18 gb L11566 1 
Ribosomal protein L29 (Rat) gb X68283 1 
Ribosomal protein S3 gb S42658 1 
Ribosomal protein S8 gb X67247 1 
Ribosomal protein S20 gb D11781 1 
RNA binding protein (Mouse) gb L17076 1 
Ro ribonucleoprotein autoantigen gb M32294 2 
Small nuclear ribonucleoprotein gb M57937 1 
Small nuclear ribonucleoprotein protein SM-D gb J04615 1 
snRNA U6 gb M59362 1 
Translationally controlled tumor protein gb X16064 1 
8) Membrane associated 
Beta-amyloid A4 gb M18134 1 
Chloride channel gb Z30643 1 
MUC18 glycoprotein (Mouse) gb X74628 1 
Nephritis transmenJDrane protein (Rat) gb L07318 1 
Oncofetal antigen (Mouse) gb U06662 1 
Presumptive KDEL receptor gb X55885 1 
Rod outer segment membrane protein 1 gb M96759 1 
9) Heat shock protein 
Heat shock protein 27 gb X54079 1 
Heat shock protein 40 gb M79244 1 
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10) other metabolism 
Cholesterol 7-alpha hydroxylase gb L07951 1 
Natural killer cell enhancing factor gb L19185 1 
Peroxisomal 3-oxacyl-CoA thiolase emb X65145 1 
Ubiqiutin conjugated enzyme gb Z29328 1 
Wistar peroxisomal enoyl hydratase protein (Rat) gb U08976 1 
11) Miscellaneous 
Anonymous gene gb L18972 1 
Beta-enolase gb X16504 1 
Calmodulin gb M78211 1 
Cathepsin B (Cow) gb L06075 1 
DNF1552 gb J03068 1 
Medium tumor antigen-associated protein gb M31786 1 
Murine sarcoma 3611 viral 1 oncogene homolog gb L24038 1 
Novel protein AHNAK gb M80899 1 
Nuclear pore complex protein gb Z25535 1 
P311 (Mouse) gb X70398 1 
Placental protein 14 gb M34046 1 
Reticulocalbin (Mouse) gb D13003 1 
Thyroid autoantigen gb J04607 1 
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3.5 Sequence determination of hryL29 (Law et aL, 1996) 
3.5.1 Cycle Taq sequencing of hrpL29 
Among the 5164 cDNA clones that has been sequenced 
(S.K.W. Tsui, Ph.D. thesis; W.Y. Lam, Mphil. thesis; N.Y.H. Yam, 
Mphil. thesis; A.S.Y. Lo, MphiL thesis), one of the ESTs that was 
of interest was Xgtll-C095. The putative identity of this cDNA 
clone is the human large subunit ribosomal protein L29, since it 
matched closely with the rat large subunit ribosomal protein 
L29 (Chan et. al., 1993). 
The designated name for the human large subunit 
ribosomal protein L29 is hRPL29 and the Genbank accession 
number is U10248. The result ofhomology search of hrpL29 
with other known DNA sequences in the database by using the 
BLASTN server and the sequence profile of hrpL29 generated by 






Sequences producing High-scoring Segment Pairs: Score P(N) N 
gb|U10248|HSU10248 Human ribosomal protein L29 (humrpl2... 1760 2.4e-217 2 
emb|Z4 9148|HSRPL29 H.sapiens mRNA for ribosomal protein... 1760 7.6e-216 2 
embIX682831RNRPL29 R.norvegicus mRNA for ribosomal prot... 1346 l.le-135 3 
gb|L086511MUSRP7 5A Mus musculus large ribosomal subunit... 1150 1.3e-129 4 
embIX60744|RNRPYL43 Rat mRNA for ribosomal protein relat... 1337 4.6e-122 2 
gb1L08652|MUSRP77B Mus musculus large ribosomal subunit... 686 9.6e-97 4 
dbj|D44602|YSCF9765J Saccharomyces cerevisiae chromosome ... 280 4.7e-13 1 
dbjID50617|YSCCHRVIN Saccharomyces cerevisiae chromosome ... 280 4.7e_13 1 
gb|U40226|DMU40226 Drosophila melanogaster 60S ribosoma... 256 2.8e-ll 1 
gb|S66865|S66865 pnt=pointed {P1 transcript, alternat... 168 0.0011 1 
embIX69166|DMPOINTlA D.melanogaster mRNA for ETS-like pro... 168 0.0011 1 
dbjID832681AT1VUTEL1 Athalia rosae Adult dayl/day2 female... 150 0.029 1 
dbj|D28412|HUMRPY71 Human mRNA for ribosomal protein YL4... 110 0.78 1 
gb|M88749|ICHVITGN Lamprey vitellogenin mRNA, complete ... 130 0.82 1 
gb|L37 368|HUMRBPB Human (clone E5.1) RNA-binding prote... 128 0.91 1 
gb|M2 9297|STMTN4556 S.fradiae class II transposable elem... 127 0.95 1 
gb|M15847|RABHBAL2 Rabbit alpha-like globin gene cluste... 110 0.97 2 
<gb|M1584 6|RABHBAL4 Rabbit alpha-like globin gene cluste... 110 0.99 2 
emb|X92692|HRMRNA628 H.rubra mRNA for putative abalone pr... 123 0.997 1 
dbj I D16505|CHWEF3 Chlorella virus DNA for translation … 122 0.9996 1 
emb|Z70756|CET06E4 Caenorhabditis elegans cosmid T06E4 122 0.9997 1 
gb|L11451|DROSTUBBLE Drosophila melanogaster serine prote... 121 0.99993 1 
gb|U10248|HSU10248 Human ribosomal protein L29 (humrpl29) mRNA, complete cds. 
Length = 630 
Plus Strand HSPs: 
Score = 1760 (486.3 bits). Expect = 2.4e-217, Sum P(2) = 2.4e-217 
Identities = 352/352 (100%), Positives = 352/352 (100%), Strand = Plus / Plus 
Q u e r y : 1 GGCTTATGGTGCAGACATGGCCAAGTCCAAGAACCACACCACACACAACCAGTCCCGAAA 60 
I I 1 I I 1 I I I I 1 I 1 I 1 I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I 
S b j c t : 14 GGCTTATGGTGCAGACATGGCCAAGTCCAAGAACCACACCACACACAACCAGTCCCGAAA 73 
Query: 61 ATGGCACAGAAATGGTATCAAGAAACCCCGATCACAAAGATACGAATCTCTTAAGGGGGT 12 0 
1 I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I 
S b j c t : 74 ATGGCACAGAAATGGTATCAAGAAACCCCGATCACAAAGATACGAATCTCTTAAGGGGGT 133 
Q u e r y : 121 GGACCCCAAGTTCCTGAGGAACATGCGCTTTGCCAAGAAGCACAACA7W\AGGGCCTAAA 180 
I I 1 I 1 I 1 I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I 
S b j c t : 134 GGACCCCAAGTTCCTGAGGAACATGCGCTTTGCCAAGAAGCACAACAAAAAGGGCCTAAA 193 
Q u e r y : 181 GAAGATGCAGGCCAACAATGCCAAGGCCATGAGTGCACGTGCCGAGGCTATCAAGGCCCT 240 
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I 
• S b j c t : 194 GAAGATGCAGGCCAACAATGCCAAGGCCATGAGTGCACGTGCCGAGGCTATCAAGGCCCT 253 
Q u e r y : 241 CGTAAAGCCCAAGGAGGTTAAGCCCAAGATCCCAAAGGGTGTCAGCCGCAAGCTCGATCG 300 
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I 
Sbj ct: 254 C G T A A A G C C C A A G G A G G T T A A G C C C A A G A T C C C A A A G G G T G T C A G C C G C A A G C T C G A T C G 313 
Query: 301 ACTTGCCTACATTGCCCACCCCAAGCTTGGGAAGCGTGCTCGTGCCCGTATT 352 
I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I Sbj ct: 314 ACTTGCCTACATTGCCCACCCCAAGCTTGGGAAGCGTGCTCGTGCCCGTATT 365 
Figure 3.3 The homology search of hrpL29 with other deposited 
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3.5.2 Subcloning of the hrpL29 cDNA insert into the pUC18 
DNA cloning vector 
For a better sequencing quaHty and for other future 
purposes, the cDNA insert of hrpL29 was subcloned into the 
EcoRl site of the pUC18 cloning vector. The procedures for the 
subcloning of cDNA are described in section 2.2 and 2.3. 
Plasmid DNA was prepared from the suspected transformants in 
a mini scale (Figure 3.5) and the putative candidates were 
subjected to restriction digestion and cycle sequencing for 
confirmation of cloning the correct insert. 
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^^^ ^^^ ^^^ ^^  j^^^^^^ ^^^ ^^^ i^j^^ ^^^ ^^^ |^^ |j|j^^ ^^^ ^^^ ^^^ ^^^ ^^^ ^^^ ^^j^jlinpljiypipi^^ l^^|^ljj^ijppm^^ 
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“ ^ , kmrn^^ . U m m m m 
Figure 3.5 Mini scale preparation of plasmid DNA from 28 
suspected transformants. The suspected candidates are shown 




3.5.3 Unicycle T7 sequencing of hrpL29 
The recombinant pUC18 plasmid which carried the cDNA 
of hrpL29 was prepared in a large scale (Section 2.3.2) for 
sequencing using the T7 polymerase (Section 2.12). Although 
the unicycle T7 sequencing reaction requires more DNA 
template than cycle sequencing, a clearer and longer DNA 
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3.6 Sequence alignment and comparison of hrpL29 with 
other known sequences in the databases. 
When the nucleotide sequence of hrpL29 was analysed by 
the program MacDNASIS^^ (HIBIO), the DNA sequence of 
hrpL29y excluding the poly-A tail, is 630 bp in length and 
contains an open reading frame yielding a predicted translation 
product of 159 amino acids (Figure 3.7). The longest open 
reading frame begins at an ATG codon at nucleotide 30 and 
ends with a termination codon (TAG) at position 507. The 
initiation codon occurs in the context GACATGG and the 
consensus is RCCATGG (R represent purine) (Kozak, 1986). The 
posttranscriptional cleavage and polyadenylation signal 
(AATAAA) (Proudfoot and Brownlee, 1976) are at position 613-
618. 
When the sequence of hrpL29 was aKgned with other 
known sequences by the program MacDNASIS, it matches at 
the nucleotide level with the large subunit ribosomal protein 
L29 from rat (rRPL29) (Chan et. al., 1993) with 77.4% identity 
(Figure 3.8). The amino acid sequence of hrpL29 also shows 
80.4% homology to rat L29 and is related to Yeast YL43 ( Otaka. 
et.al., 1984)(Figure 3.9). 
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1 M A K S K N 6 
1 GT TCG GGA GCC GCG GCT TAT GGT GCA GAC ATG GCC AAG TCC AAG AAC 47 
7 H T T H N Q S R K W H R N G I K 22 
48 CAC ACC ACA CAC AAC CAG TCC CGA AAA TGG CAC AGA AAT GGT ATC AAG 95 
23 K P R S Q R Y E S L K G V D P K 38 
96 AAA CCC CGA TCA CAA AGA TAC GAA TCT CTT AAG GGG GTG GAC CCC AAG 143 
39 F L R N M R F A K K H N K K G L 54 
144 TTC CTG AGG AAC ATG CGC TTT GCC AAG AAG CAC AAC AAA AAG GGC CTA 191 
55 K K M Q A N N A K A M S A R A E 70 
192 AAG AAG ATG CAG GCC AAC AAT GCC AAG GCC ATG AGT GCA CGT GCC GAG 239 
71 A I K A L V K P K E V K P K I P 86 
240 GCT ATC AAG GCC CTC GTA AAG CCC AAG GAG GTT AAG CCC AAG ATC CCA 287 
87 K G V S R K L D R L A Y I A H P 102 
288 AAG GGT GTC AGC CGC AAG CTC GAT CGA CTT GCC TAC ATT GCC CAC CCC 335 
103 K L G K R A R A R I A K G L R L 118 
336 AAG CTT GGG AAG CGT GCT CGT GCC CGT ATT GCC AAG GGG CTC AGG CTG 383 
119 C R P K A K A K A K A K D Q T K 134 
384 TGC CGG CCA AAG GCC AAG GCC AAG GCC AAG GCC AAG GAT CAA ACC AAG 431 
135 A Q A A A P A S V P A Q A P K R 150 
432 GCC CAG GCT GCA GCC CCA GCT TCA GTT CCA GCT CAG GCT CCC AAA CGT 479 
151 T Q A P T K A S E * 160 
480 ACC CAG GCC CCT ACA AAG GCT TCA GAG TAG ATA TCT CTG CCA ACA TGA 527 
528 GGA CAG AAG GAC TGG TGC GAC CCC CCA CCC CCG CCC CTG GGC TAC CAT 575 
576 CTG CAT GGG GCT GGG GTC CTC CTG TGC TAT TTG TAC AAA TAA ACC TGA 623 
624 GGC AGG AAA AAA AAA AAA AAA AAA AAA AAA AAA AAA AA 630 
Figure 3.7 The DNA and deduced amino acid sequence of hrpL29, 
The initiation and termination sites were in bold and underUned. 
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10 20 30 40 50 60 
hrpLZ 9 GTTCGGGAGCCGCGGCTTATGGTGCAGACATGGCCAAGTCCAAGAACCACACCACACACA X: � : � � � � � : : � : : � � � � � � � � � � � � � � � � � � � � � : � : � � � � � � � = � � : “ •‘�� 
ratL2 9 CTCGGGGAGCCGCGGCTTACCGTGCAGACATGGCCAAGTCCAAGAACCACACCACACACA 
70 80 90 100 110 120 
hrpL2 9 ACCAGTCCCGAAAATGGCACAGAAATGGTATCAAGAAACCCCGATCACAAAGATACGAAT 
ratL2 9 i^;^(jiG&&(jcAAATGGCACAGAAATGGCATCAAGAAACCCCGGTCACAAAGATACGAAT 
130 140 150 160 170 180 
hrpL2 9 CTCTTAAGGGGGTGGACCCCAAGTTCCTGAGGAACATGCGCTTTGCCAAGAAGCACAACA 
ratL2 9 CTCTTAAAGGGGTCGACCCCAAGTTTCTGAGGAACATGCGCTTTGCCAAG7U^GCACAACA 
190 200 210 220 230 240 
hrpL2 9 AAAAGGGCCTAAAGAAGATGCAGGCCAACAATGCCAAGGCCATGAGTGCACGTGCCGAGG 
ratL2 9 A G A ^ ^ C T G A A G A A G A T G C A G G C C A A C A A T G C C A A G G C A G T G A G T G C A C G A G C A G A G G 
250 260 270 280 290 300 
hrpL2 9 CTATCAAGGCCCTCGTAAAGCCCAAGGAGGTTAAGCCCAAGATCCCAAAGGGTGTCAGCC 
： : : : : : : : : : : : : : : : : : : : : : : ：：::::::::::::::::::: ::::: 
ratL2 9 CCATCAAGGCCCTCGTGAAGCCTCAGGCTGTCAAGCCCAAGATGCCAAAGGGCTCCAGCC 
310 320 330 340 350 360 
hrpL2 9 GCAAGCTCGATCGACTTGCCTACATTGCCCACCCCAAGCTTGGGAAGCGTGCTCGTGCCC 
: : : : : : : ：：：：：：：:: :：： : : : : : : : : : : : : : : : : : : ::: = 
ratL29 GCAAACTCAGCCGTCTGGCTTTCATCGCTCACCCCAAGCTTGGGAAGAAGATTCGAAGCT 
370 380 390 400 410 420 
hrpL2 9 GTATTGCCAAGGGGCTCAGGCTGTGCCGGCCAAAGGCCAAGGCCAAGGCCAAGGCCAAGG 
： ： : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : ： ::::::: ::: 
ratL2 9 ACATGGCCAAGGGTCGTAGGCTCTGCCAACCAAAGCCCAAGGTTCAAACCAAGGCAGAGG 
430 440 450 460 470 480 
hrpL2 9 ATCAAACCAAGGCCCAGGCTGCAGCCCCAGCTTCAGTTCCAGCTCAGGCTCCCAAACGTA � � � : : : : :  : : : � :: : : � � � � � � � � � � � � � � � � �  • 
ratL2 9 CCAAAGCTCCAGCTAAGGCCCAGGCCAAAGCTCCAGCCCAGGCTCCCAAGGGTG 
490 500 510 520 530 540 
hrpL2 9 CCCAGGCCCCTACAAAGGCTTCAGAGTAGATATCTCTGCCAACATGAGGACAGAAGGACT 
: : : : : : : : : : : : : : : : ：：：：：： :::::: ::::::::: :::: 
- ratL29 CCCAGGCCCCTGTGAAGGCCCCATAGAACAGGCTCCTGCCAGTGTGAAGACAGACAGACT 
550 560 570 580 590 600 
hrpL2 9 GGTGCGACCCCCCACCCCCGCCCCTGGGCTACCATCTGCATGGGGCTGGGGTCCTCCTGT � � � : : : : : : : : : : : � � ^ � � ��� �  V � : : : : : � 
ratL2 9 GCTGTGA CACACCC--ACCTACAC-ACTATCTGCAGATGACCAGTGTCCTATGCT 
610 620 
hrpL29 GCTATTTGTACAAATAAACCTGAGGCA 
• • • • 參 » • 
• • • • • 參 寿 
ratL29 GTTTTTACAAATAAACTTGAGACAAGA 
Figure 3.8 AUgnment of hrpL29 with rat large subunit 
ribosomal protein L29 by using the program MacDNASIS^^. 
Nucleotides that are identical between two sequences are 
marked by “:”• 
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70 80 90 100 110 120 
hRPL2 9 NAKAMSARAEAIKALVKPKEVKPKIPKGVSRKLDRLAYIAHPKLGKRARARIAKGLRLCR 
• • • • • • • • • • • • • • 春 • • • • • : • r * J J 鲁 _ 攀 攀 等 • 攀 鲁 • 參 • _ 0 參 眷 9 a _ _ • • 參 鲁 • • • 
rRPL29 NAKAVSARAEAIKALVKPQAVKPKMPKGSSRKLSRLAFIAHPKLGKKIRSYMAKGRRLCQ 
130 140 150 
hRPL2 9 PKAKAKAKAKDQTKAQAAAPASVPAQAPKRTQAPTKASE 
• • • • • • • • • • • J • J J J J • • J J , J J ^ 
rRPL2 9 PKPKVQTKA--EAKAPAKAQAKAPAQAPKGAQAPVKAP 
Figure 3.9 AUgnment of hRPL29 with rRPL29 and YL43 using 
the HIBIO software package (Hitachi), which shows that hRPL29 
shares 80.4% and 78.9% identity with rRPL29 and YL43 
respectively. Regions that are identical and simaar between the 
sequences are marked by “:” and “.” respectively. 
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3.7 The primary structure of hrpL29 
In order to have a better understanding of the primary 
structure of hRPL29, the deduced amino acid sequence of 
hrpL29 was analysed by the program MacDNASIS^^. It shows 
that the deduced molecular weight of hRPL29 is 17,751 (159 
a.a.). The protein is a lysine rich protein (Figure 3.10) and it 
carries no prominent hydrophobic region (Figure 3.11). The 
estimated pI of hRPL29 is 12.16 (Figure 3.12) and the deduced 
2D protein structure was depicted in figure 3.13. 
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amino AniH +inf Mn %_LM. 2j] ^ ^ ^ ^ 
Ala A 27 16.88 m m ^ ^ ^ m 
Arg R 15 9.38 " ^ 
Asn N 7 4.38 � 
Asp D 3 1.88 • 
Cys C 1 0.62 
Gln Q 7 4.38 � 
Glu E 4 2.50 • 
Gly G 6 3.75 • 
His H 5 3.12 • 
Ile I 5 3.12 _ 
Leu L 9 5.62 — 
Lys K 32 20.00 " ^ " ^ ^ " 
Met M 4 2.50 • 
Phe F 2 1.25 • 
Pro P 11 6.88 “ ™ 
Ser S 8 5.00 一 
Thr T 5 3.12 • 
Trp W 1 0.62 
Tyr Y 2 1.25 • 
Val V 5 3.12 • 
Asx B 0 0.00 
Glx Z 0 0.00 
*** * 1 0.62 
Xxx X 0 0.00 L 
Figure 3.10 The deduced amino acid contents of hRPL29 as 
determined by MacDNASIS^ ,^ which shows that hRPL29 is 
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-54 1 1 1 1 1 
1 33 65 97 129 160 
Figure 3.11 Hydrophobicity plot of hRPL29 as determined by 
MacDNASISTM (Hopp and Woods, 1981). Positive values indicate 
hydrophiUc regions and negative values indicate hydrophobic 




Amino Acid Number pKa 
- <Positive> 
50 “ ^^""^^^--^...^_^^ Arg(R) 15 12.5 
40 - ^ ^ ^ »^^^ His(H) 5 6.0 
N^^^ Lys(K) 32 10.5 
30 - \ <Negative> 
\ Asp(D) 3 3.9 
2° _ \ Cys(C) 1 8.3 
10 • \ Glu (E) 4 4.3 
\ ^ Tyr(Y) 2 10.1 
0 ^ 
\ ^ N terminal Met {M) 9.3 
- 1 0 • — 
_20 - C—terminal Glu (E) 2.2 
-30 -
,^ . Isoelectric point [pI] 12.16 
—40 
-50 -
~~i 1 1 1 1 1 1 1 1 1 r ~ I 1 
1 7 14 pH 




10 20 30 40 50 60 70 MAKSKNHTTHNQSRKWHRNGIKKPRSQRYESLKGVDPKFLRNMRFAKKHNKKGLKKMQANNAKAMSARAE 
HELIX hhHHHHHHh hHHHhhhhHHHHHHHHH 
SHEET s sSSSs sssss 
TURN TTTTTTTTTTTTTTTTT TTTTTTT TTTT TTTTTT TTTT 
COIL CCC CC cccccc 80 90 100 110 120 130 140 AIKALVKPKEVKPKIPKGVSRKLDRLAYIAHPKLGKRARARIAKGLRLCRPKAKAKAKAKDQTKAQAAAP 
HELIX HHHHHHH HHHhhhHHhhhhHHHHHHHHH hhhhHHHHHHHhhhhHHHHH 
SHEET sssss SSSs sSSSSSS sssss 
TURN TTTTT TTTT TTTT TTTT 





TURN TTTTT TTTT 
COIL CCCCCC CCC 
Figure 3.13 The two dimensional protein structure of 
hRPL29 as determined by MacDNASIS^ .^ H (h) for heUx; 
S (s) for sheet; T � for turn; and C (c) for coil. Lower 
case means there is a posibiUty that the residue occurs 
in the indicated conformation. Upper case means a 
probabiUty is predicted. 
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3.8 Results of RT-PCR and PCR 
The protocol for preparation of the total RNA and the 
synthesis of the first strand cDNA has been described in 
sections 2.16.1 and 2.17. The integrity of the prepared total 
RNA was checked by electrophoresis in 1% agarose 
formaldehyde gel (Figure 3.14) and the quantity ofthe total RNA 
in each lane was adjusted by optical density measurements of 
the RNA preparation. 
The results of the PCR using the first strand cDNA 
prepared from different tissues and myocytes of rat showed that 
there is an ampUfied PCR product of a size of approximately 
800bp which is very close to the predicted length (Figure 3.15). 
In order to check the quaHty and integrity of the first strand 
cDNA, a pair of actin specific primers was used to ampUfy the 




1 2 3 4 5 6 7 8 
^^^^^^M 
28S_ • ^ ^ r ~ • 
_ 
b M M l 
‘ 
Figure 3.14 Formaldehyde gel electrophoresis of total RNA 
prepared from different rat tissues. Lane 1: Heart; Lane 2: 
Brain; Lane 3: Spleen; Lane 4: Kidney; Lane 5: Muscle; Lane 6: 
Liver; Lane 7: Liver; Lane 8: Intestine. 
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1 2 3 4 
丨 • 
800bp - ^ ^ ^ ^ ^ ^ ^ ^ H 
• U ^ ^ H 
n H 
Figure 3.15 PCR of the first strand cDNA prepared from 
different tissues and myocytes of rat using the C095-ATG and 
dT primers. Lane 1: Heart; Lane 2: Muscle; Lane 3: Myocytes; 




1 2 3 4 5 
_ 
t3^^m^ 
Figure 3.16 Agarose gel electrophoresis gel analysis of the 
results of PCR by using a pair of actin specific primers to 
ampUfy the first strand cDNA prepared from different rat 
tissues. Lane 1: Heart; Lane 2: Brain; Lane 3: Spleen; Lane 4: 
Intestine; Lane 5: Muscle. 
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3.9 Genomic analysis of hrpL29 
3.9.1 Isolation of the first intron of hrpL29 
Most of the mammaHan ribosomal proteins are 
characterized by carrying only a single functional copy of gene 
in the presence of multiple non-functional pseudogenes. To 
differentiate the functional copy from the intxonless 
pseudogenes, an intron specific probe was synthesized (Davies. 
et.al., 1989). A pair of coding region specific primers within the 
first 100 bp are designed (Figure 3.17). The forward and reverse 
primers are anchored with Pstl and Hindlll sites, respectively. 
An end clamp sequence TAG GGC is included at the 5, end of 
both primers to ensure the integrity of the anchored restriction 
sites after the PCR using human genomic DNA prepared in 
section 2.15.1 as the template. Agarose gel electrophoresis of 
the PCR products depicted two ampUfied bands (Figure 3.18). 
The lower band (approximately 100 bp) is expected to be present 
if hrph29 pseudogenes were ampUfied. The upper band 
(approximately 400 bp), containing the putative intron, was 
excised from the gel and cloned into pUC18 cloning vector. The 
insert was then sequenced using the universal primer. The 
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insert was found to contain a 329 bp intxon specific to hrpL29. 
Sequences flanking the intron, i.e. 33 bp at the 5’ end and 53 bp 





1 M "S K S K JT" 6 
1 GT TCG GGA GCC GCG GCT TAT GGT GCA GAC ATG GCC AAG TCC AAG AAC 47 
7 ^ T T H N Q S R K W H R N G I K 22 
48 CAC ACC ACA CAC AAC CAG TCC CGA AAA TGG CAC AGA AAT GGT ATC AAG 95 
B 
23 K P R ^ “ S Q R Y E S L K G V D P K 38 
96 AAA CCC CGA TCA CAA AGA TAC GAA TCT CTT AAG GGG GTG GAC CCC AAG 143 
39 F L R N M R F A K K H N K K G L 54 
144 TTC CTG AGG AAC ATG CGC TTT GCC AAG AAG CAC AAC AAA AAG GGC CTA 191 
55 K K M Q A N N A K A M S A R A E 70 
192 AAG AAG ATG CAG GCC AAC AAT GCC AAG GCC ATG AGT GCA CGT GCC GAG 23 9 
71 A � K A L V K P K E V K P K I P 86 
240 GCT ATC AAG GCC CTC GTA AAG CCC AAG GAG GTT AAG CCC AAG ATC CCA 287 
87 K G V S R K L D R L A Y I A H P 102 
288 AAG GGT GTC AGC CGC AAG CTC GAT CGA CTT GCC TAC ATT GCC CAC CCC 335 
C • 
103 K L G K R A R A R I A K G L R L 118 
336 AAG CTT GGG AAG CGT GCT CGT GCC CGT ATT GCC AAG GGG CTC AGG CTG 383 
119 C R P K A K A K A K A K D Q T K 134 
384 TGC CGG CCA AAG GCC AAG GCC AAG GCC AAG GCC AAG GAT CAA ACC AAG 431 
135 A Q A A A P A S V P A Q A P K R 150 
432 GCC CAG GCT GCA GCC CCA GCT TCA GTT CCA GCT CAG GCT CCC AAA CGT 47 9 
JD 
151 T Q A ^ T K A S E ~ 160 
480 ACC CAG GCC CCT ACA AAG GCT TCA GAG TAG ATA TCT CTG CCA ACA TGA 527 
528 GGA CAG AAG GAC TGG TGC GAC CCC CCA CCC CCG CCC CTG GGC TAC CAT 575 
576 CTG CAT GGG GCT GGG GTC CTC CTG TGC TAT TTG TAC AAA TAA ACC TGA 623 
‘ 624 GGC AGG A � ° 
Figure 3.17 The location of primers employed in the PCR ofspecific 
regions are indicated by arrows. Primers A and B (flanking 100 bp) were 
designed for PCR using genomic DNA as template while Primers C and D 






Figure 3.18 Agarose gel electrophoresis of PCR products 
generated from human genomic DNA using primers (A and B) 
derived from the first 100 bp of cDNA sequence of hrpL29. 
pUC19 Taql/Sau3a (lane 1)，PCR using 700ng human genomic 
DNA as template (lane 2). 
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1 ccaagtccaagaaccacaccacacacaaccagtGTAAGTTTTTTTGGGGC CCTGCCTACC 60 
61 ATCCCAGACC CTGGACAAGG GCTGGGTTTC AGGGCAAAAC TGGAGACAGA GATGAAGGGG 120 
121 GCACGTTTCC ATTGTGGGCC TGAGGCTGAT TGATTTCACC CAGTAATAAC TTTAGGGTTT 180 
181 ATAGGTTTAG AGATCTACTT GAGATACAGA GTGTTTTGCA TTTAGTAGTA AGGGTGTCCC 240 
241 ATATCTCAAG TGTAGCTGCT GTAGGAAGTG TTGGTTCTCC CCAGACTTGC CAGCTGTGAT 300 
301 GTTGGGTGGG CTTATTAGAG GAAAGTTCTT TGTTGGCTTA ATTCCCTTTT TTTCTCCCAC 360 
361 AGcccgaaaatggcacagaaatggtatcaagaaaccccgagcacaaagagacgaa 415 
Figure 3.19 The nucleotide sequence of the upper band or the 
putative intron. The lowercase characters denote homology to the 




3.9.2 Southern analysis of hrpL29 
When studying the gene organization of hrpL29, the exon 
specific DNA fragment ampMed by PCR using the exon specific 
primers (primer C and D) and Agtll-C095 as the template was 
used as the probe (Figure 3.17). The preparation of genomic 
DNA from the leukocytes was described in section 2.15.1 and 
the integrity of the prepared undigested genomic DNA was 
checked by electrophoresis of the DNA in 0.7% agarose in TBE 
(Figure 3.20). Southern blot analysis shows that the human 
L29 gene is not specified by a single gene copy. The gene copy 
number of hrpL29, indicated by the number of bands, is 
approximately 10 (Figure 3.21, Figure 3.22). 
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2 3 . 6 ^ 9 
H B ^ H | 
^ H ^ ^ ^ H 
國 m 
Figure 3.20 The integrity of genomic DNA prepared from the 
human blood sample. Lane 1: XHindlll DNA marker; Lanes 2 
and 3: 1:20 diluted; Lanes 4 and 5: 1:30 diluted. 
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Figure 3.21 Restriction digest of human genomic DNA isolated 
from normal human blood ceUs. About 13^ ig of genomic DNA 
was restricted either with EcoRl (Lane 1), Hindlll (Lane 2) or 
BawHl (Lane 3) and then fractionated by a 0.7% agarose TBE 
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Figure 3.22 Genomic Southern analysis of the hrpL29 gene 
using the 170 bp exon specific probe generated by primers C 
and D and the cDNA insert as the template. The genomic DNA 




When the intron of hrpL29 (Section 3.9.1) was used to 
probe a Southern blot of human genomic DNA digested with 
either HindIII, BamRl or Psfl, only a single band was detected, 
implying that only a single copy of the intron-containing gene 
is present in the human genome (Figure 3.23). This result is in 
contrast to the multiple bands observed when a similar 
Southern blot is hybridized with the exon specific fragment 
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Figure 3.23 Genomic Southern analysis of the hrpL29 gene 
using the 400 bp upper band as the probe. The genomic DNA 
was digested with Hmdlll (lane 1), BawHl (lane 2) and Pstl (lane 
3). Corresponding sizes of the marker bands are indicated. 
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3.10 Northern analysis of hrpL29 
3.10.1 Tissue distribution of hrpL29 mRNA in rat tissues 
Northern analysis using the cDNA insert as the 
hybridization probe and total RNA from human fetal heart, rat 
adult heart, brain, spleen, and kidney indicated the presence 
of only one hrpL29 mRNA species of approximately 800bp, a 
size very close to the insert of >,gtll-C095 (Figure 3.24 and 
3.25). The rat Northern blot was quantitated by optical density 
measurement to confirm each lane has approximately the 





800bp ^ ^ m 
Figure 3.24 Northem analysis of hrpL29 mRNA. Total RNA 
was extracted from human fetal heart (lanel). The amount of 
total RNA loaded is approximately 30^g 
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Figure 3.25 Northern analysis of hrpL29 mRNA. Rat adult 
heart (lane 5), rat brain (lane 6), rat spleen (lane 7) and rat 
kidney (lane 8). Lanes 1 to 4 are the corresponding ethidium 
bromide stained gel quantitated by image scanning to confirm 
each lane has approximately 30^g RNA loaded. 
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3.10.2 Time course of hRPL29 expression in mouse heart 
The expression profUe of hRPL29 in mouse (Balb/c) heart 
through time is shown in figure 3.26. The relative amount of 
total RNA in each lane was quantitated by optical density 
measurement to ensure that in each lane, 30 i^g of total RNA 
was loaded (Figure 3.27). To show that each lane had 
approximately equal amount of total RNA loaded, the RNA blot 
was normaUzed by the human gIyceraldehyde 3 phosphate 
dehydrogenase (hG-3-PDH) which is constantly expressed in 
different tissues (Figure 3.28). 
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Figure 3.26 Time course expression of hRPL29 in mouse 
heart. Day 1 (Lane 1); Day 2 (Lane 2); Day 4 (Lane 3); Day 6 
(Lane 4); Day 8 (Lane 5); Day 14 (Lane 6); Day 21 (Lane 7); Day 
28 (Lane 8); and adult (Lane 9) 
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Figure 3.27 Ethidium bromide stain of the gel used for the 
study of time course expression of hRPL29 in mouse heart. 
Day 1 (Lane 1); Day 2 (Lane 2); Day 4 (Lane 3); Day 6 (Lane 4); 
Day 8 (Lane 5); Day 14 (Lane 6); Day 21 (Lane 7); Day 28 (Lane 
8); adult (Lane 9) 
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Figure 3.28 NormaUzation using the human glyceraIdehyde 3 
phosphate dehydrogenase (hG-3-PDH) as the hybridization 
probe. Day 1 (Lane 1); Day 2 (Lane 2); Day 4 (Lane 3); Day 6 
(Lane 4); Day 8 (Lane 5); Day 14 (Lane 6); Day 21 (Lane 7); Day 
28 (Lane 8); adult (Lane 9) 
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3.10.3 Time course of hRPL29 expression in mouse brain 
The expression profile of hRPL29 in mouse (Balb/c) brain 
through time is shown in figure 3.29. The relative amount of 
total RNA in each lane was quantitated by optical density 
measurement to ensure each lane had approximately 30 i^g of 
total RNA loaded (Figure 3.30). The autoradiography of the 
Northern blot normaUzed by using the human glyceraldehyde 3 
phosphate dehydrogenase (hG-3-PDH) as the probe was shown 
in figure 3.31. 
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Figure 3.29 Time course expression of hRPL29 in mouse 
brain. Day 1 (Lane 1); Day 2 (Lane 2); Day 4 (Lane 3); Day 6 
(Lane 4); Day 8 (Lane 5); Day 14 (Lane 6); Day 21 (Lane 7); Day 
28 (Lane 8); adult (Lane 9) 
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Figure 3.30 Ethidium bromide stain of the gel used for the 
study of time course expression of hRPL29 in mouse brain. 
Day 1 (Lane 1); Day 2 (Lane 2); Day 4 (Lane 3); Day 6 (Lane 4); 
Day 8 (Lane 5); Day 14 (Lane 6); Day 21 (Lane 7); Day 28 (Lane 
8); adult (Lane 9) 
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Figure 3.31 NormaKzation using the human gIyceraldehyde 3 
phosphate dehydrogenase (hG-3-PDH) as the hybridization 
probe. Day 1 (Lane 1); Day 2 (Lane 2); Day 4 (Lane 3); Day 6 
(Lane 4); Day 8 (Lane 5); Day 14 (Lane 6); Day 21 (Lane 7); Day 





4.1 Characterization ofthe ESTs 
The similarities identified by the BLAST programmes were 
considered statisticaUy significant with a Poisson P-value <0.01 
(Adams et al, 1993; Coulson, 1994). The Poisson P-value is the 
probabiUty of as high a score occurring by chance, given the 
number of residues in the query sequence and the database. 
According to the database searches, the 502 ESTs were classified 
into eight groups as shown in chapter three, table 3.2. Five of the 
eight groups, with 203 of the sequences (40.5% of the total), 
consist of matches to human sequences: Alu repeat, repetitive 
elements, mitochondrial genes, ribosomal RNA genes, and nuclear 
genes. Twenty of the sequences (4.0%) match with non-human 
entries in GenBank, whereas 60 ofthe sequences (12.0%) match 
to the existing ESTs in the database. However, this number is an 
approximation because the number of human EST sequences in 
the GenBank non-redundant databases increased appreciably 
over the period during which this project was carried out. The 




The human and non-human matched sequences were 
further divided into eleven groups, according to the function of the 
identified gene products (Table 3.4 and 3.5). The percentage 
composition of the different categories were listed as foUows: 
Contractile element (14.2%), cytoskeleton and related proteins 
(10%), extraceUular matrix proteins (11.7%), proteins involved in 
energy metaboUsm (10.8%), hormones and proteins involved in 
hormonal regulation (5.0%), proteins participated in signal 
transduction and ceU regulation (3.3%), proteins of transcriptional 
and transIational machinery (22.5%), membrane associated 
proteins (5.8%), heat shock proteins (1.7%), proteins involved in 
other metaboUsm (4.2%) and misceUaneous proteins (10.8%). 
The contractile element group is one of the most abundant 
group as expected since contractile element constitutes a major 
portion of the heart ceUs. Among aU the above groups, the most 
abundant type of clone is the p-myosin heavy chain. The ESTs for 
energy metaboUsm also constitute a great portion and it reflects 
the fact that the energy requirement of the heart due to its need 
for muscle contraction is veiy high. 
Another point that should be noted is that the cDNAs coding 
for proteins that are involved in transcriptional and transIational 
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machinery (TC/TL) (22.5%) constitute the major group. Since 
similar proportion of ESTs for transcription/translation (TC/TL) 
machinery is observed in the human brain (approximately 19%) 
(Hwang et aL, 1995) and adult human hypertrophic heart 
(approximately 20%) (Dr. S. Tsui, personal communication); this 
result, therefore, reflect the fact that the basal level of protein 
synthesis required for supporting the ceU function of the non-
dividing ceUs such as heart and brain ceUs is similar. In contrast, 
the rapidly growing fetal heart and hepatocyte ceU Une exhibits a 
high level of expression of proteins for translation and 
transcription machinery (Hwang et al, 1995). Thus, these data 
seem to indicate that the relatively high levels of ESTs of TC/TL 
proteins in the fetal heart and hepatocyte are related more to rapid 
growth than to speciaHzation offunction for protein synthesis. 
The percentages of novel human transcripts as reported by 
different groups, including our own, consistently around 50%, 
showing the reproducibiHty of the EST approach in discovering 
and identifying new genes. 
4.2 Significance ofthe heart EST project 
It has been described in section one that genes expressed in 
the human heart remained largely unidentified, especiaUy those 
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related to the cardiovascular disease such as hypertension, 
atherosclerosis, coronary artery disease and heart failure. 
Therefore, characterization ofthe heart ESTs may somehow aid in 
solving the molecular puzzle of cardiac growth , function and 
disease. In our group, several other candidate genes such as the 
heat shock protein, LIM protein, 14-3-3 protein, dynactin, and 
malate dehydrogenase have been cloned and characterized. 
Up to May 1996, we have accumulated over 7,000 ESTs 
from the human adult heart, fetal heart, and adult hypertrophic 
heart. Together with our coUaborators in Toronto, we have 
accumulated over 33,000 ESTs from human heart. At the end of 
1994, Merck and Company, Inc. has finalized an agreement with 
the Genome Sequencing Center at Washington University of 
United States to sequence 400,000 ESTs, each representing 
approximately 400 base pairs of “single pass��sequence, from the 
5’ to 3，ends of 200,000 human cDNA clones (Cohen and 
Emanuel, 1994). This group works on various tissues and 
developmental stages and thus represent a large fraction of the 
human gene repertoire. New ESTs wiU be submitted to the dBEST 
on a daily basis (Boguski et al, 1994) and made available to the 
pubUc immediately through the GenBank and its international 
coUaborators, the European Bioinformatics Institutes and the DNA 
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database of Japan. As the number of ESTs accumulates, some 
genes with larger coding region may be simply obtained by 
overlapping the ESTs that match to the same non-human gene 
(Fields and Adams, 1994; Liew et aJL., 1994). 
Large scale cDNA sequencing is only the first step to coUect 
ESTs. Further analysis of these sequenced EST can reveal much 
more information concerning the heart. 1) The EST obtained may 
be used as mapping markers and for pinpointing the location of 
the gene in the genomic sequence (Brooks et al, 1992; Bonifas et 
al, 1992; Khan et cd., 1992; Khouri et al, 1989). 2) Gathering 
enough amount of ESTs, expression profiles in different tissues or 
ceU types would be a powerfiil tool in biological sciences (Adams et 
aL，1992; Adams et al, 1993a). By comparing normal and 
diseased ceUs, up- or down-regulated gene expression wiU be easily 
identified. The discovery of genes acting exclusively in a special 
tissue, (in our case, the heart) wiU profoundly affect 
pharmaceutical sciences. 3) The ESTs can be used as probes for 
fishing out fuU-length genes of interest (Adam et cd,, 1992). 
4.3 Redundancy of the EST sequencing 
The Ubraries used in our EST project are not normalized and 
aU species of cDNAs are theoreticaUy present in their original 
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relative abundance. To reduce the population of higUy 
represented gene transcripts in a cDNA Ubrary, subtxactive 
hybridization should be used to enrich the clones which are not 
commordy expressed in different Ubraries (Travis and SutcMe, 
1988; Duguid and Dinauer, 1990; FargnoU et al’ 1990; Lee et al, 
1991). The occurrence of certain genes appearing more than once 
in the Kbraiy using randomly selected cDNA clones is inevitable. 
However, the problem of redundancy is not veiy severe as most of 
the human and non-human matches appear ordy once amongst 
the 502 ESTs. In the adult heart Ubrary, however, onty one 
exceptional EST corresponding to 6-myosin heavy chain appeared 
six times out of 502 and it reflects the fact that heart muscle 
needs to contract vigorously. It has been verified that even though 
mRNAs exhibit different abundances among different tissues and 
ceU types, clones randomly chosen from non-normaHzed Ubraries 
are sufficient for effective gene discovety using the efficient EST 
approach. 
4.4 The importance of frequent database searching 
One of the problems of database searching is that since 
other groups generate more than 1000 cDNA sequences to the 
GenBank per day, the homology search results of our cDNA 
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project needs to be updated regukrly, As a result, we need to 
perform cDNA search regukrly especiaUy for those cDNAs that 
were identified as novel previously, in order to update information 
for any special cDNA of interest. 
4.5 The importance of an efGcient comparison algorithm 
Every day there are numerous ESTs submitted to the pubUc 
database for sequence similarity search. Thus, it is essential to 
develop an efficient comparison algorithm aUowing speed and 
sensitivity, and maximizing efficiency in the search procedure. 
Basic Local Mgmnent Search Tool (BLAST) is a recently 
established approach to rapid sequence comparison, which seeks 
conserved subsequences existing locaUy among sequences, rather 
than analyzing across the whole stretch of a sequence. The scoring 
system relies on a matrix of simaarity scores for aU possible pairs 
ofbases or residues. The overaU result is reflected by the smaUest 
sum probabiHty, which is derived from assigning scores to 
identities, conservative and unUkely replacements observed 
amongst sequences (Altschul et al，1990). This algorithm can 
detect weak but biologicaUy significant sequence similarities and is 
an order of magnitude faster than existing sequence comparison 
tools of comparable sensitivity, such as the FASTA program. The 
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BLAST algorithm is appUcable to sequence comparison not ohfy 
between DNA sequences, but also aUows for comparison of DNA 
sequences to protein databases. Both the BLASTN program for 
DNA homology search and BLASTX program for protein sequence 
comparison are available through the BLAST network server from 
the National Center for Biotechnology Information (Gish and 
States, 1993). 
We routinely submit ESTs through the BLAST network e-
mail server for DNA sequence similarity searches. The default 
value for the expected score (E) is recommended to be 0.75, which 
aUows a sensitive detection for sequence identities as low as 55% 
between two sequences. Each optimized matching score is 
associated with the corresponding statistical smaUest probabOity 
(P) of the two sequences matching to each other due to a random 
stochastic event. Matched identities with P values lower than lO-i� 
are considered to be clear and significant matches, though some 
exceptions were made when two sequences matched with low 
identity over long stretches of sequence, but exhibited higher P 
values. It is therefore necessajy to examine the search result of 
each EST matched with the known gene sequence, to decide if the 
match is truly meaningful. 
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4.6 Human ribosomal protein L29 (hRPL29) 
The mammaHan ribosome is a macromolecular assembly 
which consists of four different molecules of RNA and 
approximately 80 different ribosomal proteins (Wool et al, 1979; 
Wool et al, 1990). Prokaryotes, however, have only about 50 
ribosomal proteins (Otaka et al, 1981; Otaka et al, 1984). Most 
ribosomal protein genes are present at 7 to 20 copies in the 
genome (Monk et al, 1984), although some, such as rat 
ribosomal protein S5 (Kuwano et al, 1992) and human 
ribosomal protein L37a (Saha et al, 1993), are present as single 
copy genes. 
We have initiated a human heart cDNA project which is 
aimed at reveaMng the gene expression profile of human heart 
and identifying novel, previously uncharacterized genes 
expressed in the human heart (Liew et al, 1994; Liew et al, 
1993; Tsui et al., 1994a; Tsui et al., 1994b). Four out of 2000 
cDNA clones sequenced were found to exhibit homology to rat 
ribosomal protein L29 (Chan et al, 1993). 
The cDNA sequence of the human ribosomal protein L29 
(hRPL29), excluding the poly-A tail, is 630 bp in length (Figure 
3.7). The 5，end pyrimidine sequences, which have been 
suggested to play a role in the regulation of ribosomal protein 
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mRNA translation (Mariottini et al, 1990) were absent from this 
transcript. 
The hrpL29 cDNA exhibits 77.4% identity at the 
nucleotide level to the rat ribosomal protein L29 (rRPL29) (Chan 
et al, 1993) and contains an open reading frame yielding a 
predicted translation product of 159 amino acids. The predicted 
amino acid sequence is 100% identical over the first 64 residues 
and is 97% similar over the first 107 residues to rRPL29 (Figure 
3.9), suggesting an important function of the N-terminaI 
domain. The similarity (78.9%) between the N-terminal of 
hRPL29 and YL43 (Otaka et al., 1984) also suggests that the N-
terminal is functionaUy important (Figure 3.9). However, 
hRPL29 is only 57.4% similar to rRPL29 over the C-terminal 50 
residues. This region of relatively low homology is observed to be 
rich in positively charged a.a. and contains simaar numbers of 
basic residues in both rat and human sequences (12 and 13 
respectively), implying some degree of functional conservation, 
with the most saUent feature of the region being perhaps its 
high density of positive charge. 
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4.7 Intemal duplication in hRPL29 
A number of ribosomal proteins have been reported 
containing dupUcation of amino acid sequences (Table 4.1). 
When hRPL29 is searched for internal dupUcation, the largest 
tandem repeat in hRPL29 is KAKAKAKA (at position 122-129) 
(Figure 3.7). The other dupUcations are the tripeptide repeat 
QAP at 146-148 and 152-154 as weU as the tripeptide repeat 
VKP at 76-78 and 81-83. While the tripeptide repeat QAP is 
unique, the tripeptide VKP repeats are not uncommon in 
ribosomal proteins. The occurrence of multiple, related and 
generaUy basic repeats in ribosomal proteins gives us an insight 
that they may play a role in the interaction with the RNAs 
(ribosomal, transfer or messenger) or in directing the proteins to 
the nucleolus for assembly of ribosomes. There is evidence that 
some amino acid sequences are responsible for the locaHzation 
of proteins in the nucleus (DingwaQ and Laskey, 1986) although 
it is not yet possible to identify the specific consensus sequence 
for carrying out the function. It is also noted that entry into the 
nucleus is contingent on a consecutive sequence of several 
basic amino acids preceded by a prolyl residue. Several of the 
putative repeats have this characteristic, for example, rat S6 
124 
Discussion 
(Table 4.1). Since their structures are quite similar, it is possible 
that they may serve the same function. 
In addition, the ribosomal 5S rRNA is weU known for 
binding with ribosomal proteins before assembly into the 
ribosomal subunit (Guddat et al., 1990; Moritz et al, 1990; 
Deshmukh et al, 1993). In eukaryotic ceUs, the 5S rRNA wiU 
bind to one ribosomal protein whUe two to three ribosomal 
proteins wiU bind to 5S rRNA in prokaryotes (Guddat et al, 
1990; Kenmochi et al., 1992; Kim and Wu, 1993). Recently, it 
has been observed that the multiple basic amino acids (Lys and 
Arg) in the C-terminal region of the yeast ribosomal protein L1 
are responsible for binding to 5S rRNA (Lee-Chuan et al, 1995). 
Thus, the lysine rich tandem repeat KAKAKAKA may serve the 
same function as that found in the yeast L1 protein. 
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Table 4.1 Internal repeats of ribosomal proteins. 
Ribosomal proteins Internal duplicated sequence 
Rat P2 (Chan et al., 1991) EEKK(D/E); GS-APAA 
Rat L26 (Paz et al, 1989) VQV-R-KYK 
Rat S6 (Chan et al, 1988) PRRL-(K/R)(K/R) 
Rat L29 (Chan et al, 1993) KA(E/Q)AKAPA 
Human L29 (Law et al., 1996) KAKAKAKA 
4.8 Primary structure analysis of hRPL29 
hRPL29 contains a large number (27 in total) of alanine 
residues (Figure 3.10), which are clustered primaray within a 
region spanning residues 59-74 (7 Ala residues) and within the 
C-terminal portion of the protein, spanning residue 97 to the 
carboxyl terminus (18 Ala residues) (Figure 4.1). OveraQ, 
hRPL29 contained a large excess of basic residues, (32 Lys, 15 
Arg, 5 His) (shown in bold in figure 4.1) over acidic residues (4 
Glu, 3 Asp), as is observed in rRPL29 (Chan et aL, 1993). The 
basic residues tend to be clustered; for examples, 8 out of 15 
residues at position 14-28, 7 of 10 residues at position 47-56 
and 6 out of 11 residues at position 119-130. 
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The large amount of charged residues, 59 out of 159 or 
37%, makes the protein very hydrophiUc and the abundant 
basic residues, 52 out of 159 or 32.7% also account for a high 
deduced pI of 12.16 (Figure 3.12). When hRPL29 is analysed by 
MacDNASISTM，the protein has no prominent hydrophobic region 
and within a smaU. region spanning residues from 135-148, the 
number of non-polar residues is 11 out of 14 or 79% (Figure 
3.11), which is the most hydrophobic region among the whole 
sequence. Thus, it is unUkely to be a transmembrane protein. In 
addition, it is noticed that the three major alpha heUxes 
predicted by MacDNASIS^^ Ue within residues 54-77, 93-113 
and 120-139 (Figure 3.13). 
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Figure 4.1 The deduced amino acid sequence of hRPL29. The 
alanine residues are in bold and the basic residues [Lys (K), Arg 
(R) and His (H)] are underUned. 
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4.9 RT-PCR and PCR of the first strand cDNA with primers 
using the C095-ATG and dT primer 
Since the amount of template for each of the PCRs are not 
quantitated, the intensity of the DNA products may not reflect 
the actual amount of a specific species of mRNA in the sample 
(Figure 3.15). As a result, the PCRs can only serve as an 
indication of the presence of a specific species of mRNA. 
However, the results can confirm the molecular size of the 
hrpL29 mRNA which is the same as the size of the cDNA insert 
in pUC18-C095. The quaUty and integrity of the first strand 
cDNA is checked by PCR using a pair of actin primers (Figure 
3.16). 
4.10 Southern analysis of hrpL29 
Southern blot analysis using the 170 bp exon specific 
probe demonstrated that the human L29 gene is not specified 
by a single functional copy (Figure 3.22). The gene copy 
number of hrpL29, indicated by the number of bands, is 
approximately 10. This agrees with previous findings (Chan et 
al, 1993; Suzuki et al, 1990) that ribosomal proteins are 
specified by multi-copy genes and aU but one are non-functional 
pseudogenes. The multiple copies of hrpL29 is also confirmed by 
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the preUminary result of FISH mapping using the biotinylated 
cDNA probe (Figure 4.2). Since the functional copy carry the 
whole set of exons and thus the hybridization efficiency is 
assumed to be higher than the pseudogenes. As a result, it is 
most Ukely that hrpL29 is located at human chromosome 3， 
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Figure 4.2 Diagram of FISH mapping results for hrpL29 
performed by Dr. H. H. Q. Heng of SeeDNA Biotech. Inc. 
(Ontario Canada). Panel A showing the FISH signals on 
chromosome. Each dots represents the double FISH signals 
detected on human chromosome 3. Panel B showing the same 
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Figure 4.3 The schematic diagram of the chromosomal location 
of pUC18-C095. It was noticed that the hybridization efficiency 
was approximately 65% for pUC18-C095. Since the DAPI 
banding was used to identify the specific chromosomes, the 
assignment between signal from the probe and the short arm of 
chromosome 3 was obtained. It was most Ukely that the probe 




To differentiate the functional copy from the intronless 
pseudogenes, an intron specific probe was synthesized 
according to the strategy adopted by Davies et al. (Davies et al, 
1989). A pair of coding region specific primers within the first 
100 bp were designed (Figure 3.17). Agarose gel electrophoresis 
of the PCR products depicted two ampUfied bands (Fig 3.18). 
The lower band (approximately 100 bp) is expected for the 
ampUfication of hrpL29 processed pseudogenes. The upper band 
(approximately 400 bp) was excised from the gel and cloned into 
pUC18. The insert was then sequenced using the universal 
primer. The insert was found to contain a 329 bp intxon specific 
to hrpL29. Sequences flanking the intxon, i.e. 33 bp at the 5’ 
end and 53 bp at the 3’ end, were identical to the coding 
sequence of hrpL29 (Figure 3.19). When this intron specific PCR 
product was used to probe a Southern blot of human genomic 
DNA digested with HindIII, BamHl and Pstl, only a single band 
was detected, implying that only a single copy of the intron-
containing gene is present in the human genome (Figure 3.23). 
This result is in contrast to the multiple bands observed when a 
similar Southern blot is hybridized with the exon specific 
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fragment (Figure 3.22) indicating the presence of many L29 
processed pseudogenes. 
4.11 Northern analysis of hrpL29 
4.11.1 Tissue distribution ofthe mRNA species of hrpL29 
Northern analysis using the cDNA insert as the probe 
indicated the presence of only one hrpL29 mRNA species of 
approximately 800 bp in human fetal heart, rat adult heart, rat 
brain, rat spleen and kidney (Fig 3.24 and 3.25). The size of the 
message is very close to the insert of pUC18-C095 and the DNA 
fragment ampUfied by the C095-ATG and dT primers (Figure 
3.15). The RNA loading is adjusted after quantitation by image 
scanning to ensure each lane has approximately the same 
amount of total RNA loaded. 
Many of the housekeeping genes are ubiquitous and 
constitutively expressed in different tissues; for example, the 
human actin and the human glyceraldehyde-3-phosphate 
dehydrogenase (hG-3-PDH), which are often used as a 
hybridization probe for normaKzation. However, some of the 
ribosomal proteins are not coordinately expressed at the same 
level in various tissues. Unbalanced expression of ribosomal 
protein has akeady been reported in several cancers, including 
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colon. Ribosomal protein P0 was found overexpressed in colon 
cancer and in primary hepatoma (Barnard et aL, 1992a). L18, 
L37 and S6 were also elevated in colon cancer (Barnard et al, 
1992b). S19 (Kondoh et al, 1992), L31 (Chester etal” 1989), S3, 
S6, S8, S12, P0 but not L26 ,L35 (Pogue-Geile et al, 1991) or 
S13 (Denis et al., 1993) were overexpressed in colon cancer. In 
addition, porcine ribosomal protein S12 is shown to be 
differentiaUy expressed in endotheUal and smooth muscle (Zach 
et al, 1995) and the expression of human ribosomal protein S25 
is higher in rat lung and spleen than in Uver, brain, heart, 
stomach, kidney and intestine (Sun et al, 1995). In our case, it 
is noticed that hRPL29 is expressed at a higher level in the rat 
spleen than the heart, brain and kidney (Figure 3.25). 
4.11.2 Time course of hRPL29 expression in mouse heart 
and brain 
Developmental study of the expression of hRPL29 in 
mouse heart at different stages (Figure 3.26, 3.37 and 3.28) 
shows that its expression changes with time. It is highly 
expressed on the first four days after birth and thereafter the 
level of expression tends to level off. The underlying reason may 
be due to the fact that there is a remedial need for the protein 
134 
Discussion 
machinery or ribosome for protein translation during growth. In 
chick, neural crest ceUs would migrate to the cardiac outflow 
tract and participate in the division of the aorta and puhnonary 
trunk during heart development. Ablation of the posterior 
rhombencephalon, from which the neural crest ceUs originates, 
results in nondivision of the outflow vessels. Recently, chick 
ribosomal protein L10 has been found to be differentiaUy 
expressed in the outflow tract of embryos with cardiac neural 
crest (Kirby et al” 1995). Thus, the differential expression of 
hRPL29 at different stages may be vital for the growth of fetal 
heart. 
hRPL29 also shows differential expression in the 
developmental stages of mouse brain. The level of expression 
increase upon the second day after birth and the level of 
hRPL29 level off towards the later stage of sexuaUy maturity 
(Figure 3.29, 3.30 and 3.31). The higher signal in day 8 may be 
due to a sUght overloading of RNA (Figure 3.29 and 3.30). 
4.12 Possible functional role of hRPL29 
TraditionaUy, ribosomal proteins are assumed to take part 
in the translation processes only. Recently, it was found that 
some of the ribosomal proteins appear to function in roles other 
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than the translation processes. Human ribosomal protein S3 
was shown to act as an endonuclease in repair of UV-induced 
DNA damage and the first intron of S3 transcript is processed to 
generate U15A, a smaU nuclear RNA (Polakiewicz et aL, 1995). 
Phosphorylation of the serine residues at the C-terminal of 
human S6 is necessary for translation regulation (Stewart et aL, 
1994). In addition, it was demonstrated that human L7 
represents a major autoantigen of systemic autoimmune 
disease and may serve as a useful diagnostic marker for 
cUnicians (Neu et al, 1995; Von Mikecz et al, 1995). Thus, 
ribosomal proteins can have various important ceUular 
functions besides translation. Recently, it has been observed 
that the multiple basic amino acids (Lys and Arg) in the C-
terminal region of the yeast ribosomal protein L1 are 
responsible for the binding to 5S rRNA (Lee et al, 1995). Thus, 
the lysine rich tandem repeat KAKAKAKA may serve the same 
function as the yeast L1. However, the exact functions of 
hRPL29 are stiU unknown and further investigation is needed. 
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4.13 Further aspects 
Undoubtedly, a whole set of amino acid sequences of a 
particular mammaUan species is veiy important since aU 
anatytical and structural chemistry is laden with theoiy. The 
sequence is also an absolute prerequisite for determining the 
structure of mammaUan ribosomes which is, in tum, essential for 
understanding their function. The cloning and sequencing of 
hRPL29 is important as only about two-thirds ofthe approximately 
80 ribosomal proteins have been cloned and characterized. 
To ana^rse the functional aspect of hRPL29, it is necessaty 
to purify the native protein or produce the recombinant protein 
using either the prokaiyotic or the eukaryotic system. For the 
reason of easy handUng, hRPL29 can be cloned into the 
Qisiexpress vector (type IV construct, pQE-30) (QIAGEN), which 
aUows direct expression and purification of recombinant 
proteins. By studying the location of purified recombinant 
protein on the ribosome by using chemical cross-Unking and 
protection method, we can have a better understanding of the 
functional aspects of ribosomal proteins and the ribosome. 
In addition, FISH mapping using the intron fragment may 
be another functional approach to studying the hrpL29. 
Identification of the chromosomal location of a gene is 
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important as it may Knk to some genes related to genetic 
diseases. Although the genes encoding the ribosomal proteins 
are not evolutionarily related to each other, their promoters 
have approximately equivalent strength and share certain 
features such as the absence of a canonical TATA box, 
transcriptional initiation in these genes occurs precisely within 
an oUgopyrimidine tract that is flanked by four or five binding 
sites for ubiquitous transcription factors (Hariharan et al, 
1989). Thus, in the near future, the genomic sequence of 
hrpL29 should also be analysed as this information may provide 
a useful insight for understanding the transcriptional regulation 
of other ubiquitously expressed genes. For example, it was 
observed that in mouse ribosomal protein L30 the pyrimidine 
residues or the oUgopyrimidine tract spanning the start site of 
mouse L30 is essential for the efficiency of its promoter. (Safrany 
et al, 1995). 
Not much study has been reported on the protein-RNA or 
protein-protein interaction of eukaryotic ribosomal proteins 
during the ribosome assembly. It is, however, weU documented 
in prokaryotes, especiaUy in Escherichia coli. It was found that 
assembly of protein S5 and S12 shows a strong dependency on 
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S16 and S16 assembly depends in turn on S4 (Held et aL, 1974). 
Moreover, S9 and S19 also depend on S7 during assembly 
(Powers et al., 1988). Neutron diffraction studies (Capel et aL, 
1987) have shown that many of the ribosomal proteins that are 
Unked in the assembly map are near neighbors. Together with 
the isolation of specific protein-protein complex (Dijk et al, 
1977)，it has been shown that protein-protein interactions are 
an important part of ribosome assembly. It also seems that 
assembUng proteins may rely relatively less on protein-RNA 
interactions and more on protein-protein interactions. To study 
the proteins that may interact with hRPL29 during the 
assembly of ribosomal large subunit, hRPL29 can be analysed 
using the MATCHMAKER Two-Hybrid System which is a yeast-
based genetic assay to detect protein-protein interaction in vivo 
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1. PCR forward primer for Xgtl 1 22-mer 
5'-ATT GGT GGC GAC GAC TCC TGG A-3' 
2. PCR reverse primer for Xgtl 1 22-mer 
5'-TTT GAC ACC AGA CCA ACT GGT A-3' 
3. Xgtll sequencing forward primer 22-mer 
5，-XGGT GGC GAC GAC TCC TGG AGC C-3’ 
4. Xgtll sequencing reverse primer 22-mer 
5，-XGAC ACC AGA CCA ACT GGT AAT G-3， 
5. OUgo dT primer enchored with EcoRl site 30-mer 
5,-TAG GGC GAA TTC TTT TTT TTT TTT TTT TTT-3� 
6. Intron specific forward primer 29-mer 
5，-TAG GGC CTG CAG GCC AAG TCC AAG AAC CA-3， 
7. Intron specific reverse primer 32-mer 
5,-TAG GGC AAG CTT GAG ATT CGT ATC TTT GTG AT-3� 
8. Exon specific forward primer 21-mer 
5� - GAA GCG TGC TCG TGC CCG TAT-3� 
9. Exon specific reverse primer 21-mer 
5,- CTA CTC TGA AGC CTT TGT AGG-3� 
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10. C095-ATG primer 21-mer 
5，-GGC TTA TGG TGC AGA CAT GGC-3， 
11. Actin forward primer 20-mer 
5,-TCA CCA ACT GGG ATG ACA TG-3' 
12. Actin rverse primer 20-mer 




Adams, M.D., J.M. KeUey, J.D. Gocayne, M. Dubnick, M. H. 
Polymeropoulos, H. Xiao, C.R. Merril, A. Wu, B. Olde, R.F. Moreno, 
A.R. Kerlavage, W.R. McCombie, and J.C. Venter. 1991. 
Complementary DNA sequencing: expressed sequence tags and 
human genome project. Science, 252:1651-1656. 
Adams, M.D., M. Dubnick, A.R. Kerlavage, R. Moreno, J.M. KeUey, 
T.R. Utterback, J.W. Na^e, C. Fields, and J.C. Venter. 1992. 
Sequence identification of 2,375 human brain genes. Nature. 355: 
632-634. 
Adams, M.D., A.R. Kerlavage, C. Fields, and J.C. Venter. 1993a. 
3400 new expressed sequence tags identify a diversity of 
transcripts in human brain. Nature Genetics. 4:256-267. 
Adams, M.D., M.B. Soares, A.R. Kerlavage, C. Fields, and J.C. 
Venter. 1993b. Rapid cDNA sequencing (expressed sequence 
tags) from a direction^y cloned human infant brain cDNA library. 
Nature Genetics. 4:373-380. 
Aflfara, N.A., E. BentIey, P. Davey, A. Pehnear, and M.H. Jones. 
1994. The identification of novel gene sequences of the human 
adult testis. Genomics. 22:205-210. 
Altschul S. F., W. Gish, W. MiUer, E. W. Myers, and D. J. 
Lipman. 1990. Basic local aHgnment search tool. J. Mol Biol 
215:403-410. 
Anderson, C. 1993. Genome shortcut leads to problems. 
Science. 259:1684-1687. 
Backendorf, C., C. J. C. Ravensberg, J. van der Plas, J. H. van 
Boom, G. Veeneman, and J. van Duin. 1981. Basepairing potential 
ofthe 3, terminus of 16S RNA: dependence on the fiinctional state 
of the 30S subunit and the presence of protein S21. Nucl. Acids 
Res. 9:1425-1443. 
Bamard, G.F., R.J. Staniunas, S. Bao, K. Mafune, J.L. GoUan, 
G.D. Steele, Jr., and L.B. Chen. 1992a. Increased expression of 
human ribosomal phosphoprotein P0 messenger RNA in 
144 
References 
hepatoceUular carcinoma and colon carcinoma. Cancer Res. 
52:3067-3072. 
Barnard, G.F., Staniunas, R.J” M. Mori, M. Puder, M.J. Jessup, 
G.D., Steele, Jr., and L.B. Chen. 1992b. Ribosomal protein 
genes are overexpressed on colorectal cancer: isolation of a 
cDNA clone encoding the human S3 ribosomal protein. Cancer 
Res. 53:4048-4052, 
Bishop, J.O., J. G. Morton, M. Rosebach, and M. Richardson. 
1974. Three abundance classes in HeLa ceU messenger RNA. 
Nature. 250: 199-204. 
Boguski, M.S. 1994. Bioinformatics. Curr, Opin. Genet Dev. 4:383-
388. 
Bonifas, J. M., J. W. Bare, E. D. Lynch, R. V. Lebo, and E. H. 
Epstein. 1992. Regioal assignment of the juman keratin 5 
(DRT5) gene to chromosome 12q near D12S14 by PCR analysis 
of somatic ceU hybrids and multicolor in situ hybridization. 
Genomics 13:452-454. 
Brimacombe, R., J. Atmadja, A. KyriatsouUs, and W. Stiege. 
1986. RNA structure and RNA-protein neighborhoods in the 
ribosome, p. 184-202. In B. Hardesty and G. Kramer (ed.), 
Structure, Function, and Genetics ofRibosomes. Springer-Verlag, 
New York. 
Brockm6Uer, J., and R. M. Kamp. 1988. The crossUnked amino 
acids in the protein pair S13-S19 and sequence analysis of protein 
S13 of Bacillus stearothermophilus ribosomes. Biochemistry. 
27:3372-3381. 
Brooks, W., D. E. Smailus, H. U. G. Weier, and P. J. GoodfeUow. 
1992. Human repeat element-mediated PCR: cloning and 
mapping of chromosome 10 DNA markers. Genomics. 13:409-
414. 
Capel, M.S., D.M. Engebnan, B.R. Freeborn, M. Kjelgaard, J.A. 
Langer, V. Ramakrishnan, D.G. Schindler, D.K. Schneider, B.P. 
Schoenborn, I.-Y. SiUers, S. Yabuki, and P.B. Moore. 1987. A 
complete mapping of the proteins in the smaU ribosomal 
subunit ofEscherichia coll Science, 238:1403-1406. 
145 
References 
Chan, Y.L., and I.G. Wool. 1988. The primary structure of rat 
ribosomal protein S6. J. Biol Chem. 263:2891-2896. 
Chan, Y.L., and I.G. Wool. 1991. The structure of a gene 
containing introns and encoding rat ribosomal protein P2. Nucl. 
Acids Res. 19:4895-4900. 
Chan, Y.L., J. Olvera, V. Paz, and I.G. Wool. 1993. The pimary 
structure of rat ribosomal protein L29. Biochem. Biophys. Res. 
Comm. 192: 583-589. 
Chester, K.A., L. Robson, R.H.J. Begent, I.C. Talbot, J.H. 
Pringle, L. Primrose, A.J.S. Macpherson, G. Boxer, P. SouthaU, 
and A.D.B. Malcom. 1989. Identification of a human ribosomal 
protein mRNA with increased expression in colorectal tumours. 
Biochim. Biophys. Acta, 1009:297-300. 
Chomczynski, P., and N. Sacchi. 1987. Single-step method of 
RNA isolation by acid guanidinium-thiocyanate-phenol-
chloroform extraction. Anal Biochem, 162:156-159. 
CiuUa, T. A., R. M. Sklar, and S. L. Hauser. 1988. A simple 
method for DNA purification from peripheral blood. Anal 
Biochem. 174:485-488. 
Cohen, M. M .，a n d B.S. Emanuel. 1994. The company that 
genome researchers love to hate. Science, 266:1800-1803. 
Coulson, A. 1994. High -performance searching of biosequence 
databases. TIBTECH. 12:76-80. 
CundMe, E. 1986. Involvement of specific portions of ribosomal 
RNA in defined ribosomal functions: a study utiUzing antibiotics, 
P. 586-604. In B. Hardesty and G. Kramer (ed.), Structure, Function, 
and Genetics ofRibosomes. Springer-Verlag, NewYork. 
Davies, B., S. Feo, E. Heard, and M. Fried. 1989. A strategy to 
detect an intron-containing gene in the presence of multiple 
processed pseudogenes. Proa Natl. Acad. Sci. USA. 86:6691-
6695. 
Denis, M.G., C. Chadeneau, M-T. LecabeUec, B. LemouUac, B. 
Lemevel, K. Meflah, and P. Lustenberger. 1993. Over-expression 
146 
References 
of the S13 ribosomal protein in actively growing ceUs. Int J. 
Cancer. 55:275-280. 
Deshmukh, M., Y.-F. Tsay, A.G. Paulovich, and J.L. WooUbrd Jr. 
1993. Yeast ribosomal protein L1 is required for the stabiUty of 
newly synthesized 5S rRNA and the assembly of 60S ribosomal 
subunits. Mol. Cell Biol. 13:2835-2845. 
Dijk, J., J. LittlechM, and R.A. Garrett. 1977. The RNA binding 
properties of “native” protein-protein complexes isolated from 
the Escherichia coli ribosome. FEBS LeU. 77:295-300. 
DingwaU, C., and R.A. Laskey. 1986. Protein import into the ceU 
nucleus. Annu, Rev, Cell Biol 2:367-390. 
Duguid, J.R., and M.C. Dinauer. 1990. Library subtraction of in 
vitro cDNA Ubraries to identify differentiaUy expressed genes in 
scrapie infection. Nucleic. Add Res. 18:2789-2792. 
FargnoU, J., Holbrook, N.J., and A.J.Jr. Fomace. 1990. Low-ratio 
hybridization subtraction. AnoJL. Biocherru 187:364-373. 
Field C. and M.D. Adams. 1994. Expressed sequence tags identify 
a human isolog of the suil translation initiation factor. Biochem. 
Biophys. Res. Comm 198:288-291. 
Gardiner, K.J., T.L. Marsh, and N.R. Pace. 1985. Ion dependence 
of the Bacillus subtilis RNase P reaction. J. Biol. Chem. 260:5415-
5419. 
Giri, L., W.E. HiU, H. G. Wittmann, and B. Wittmann-Liebold. 
1984. Ribosomal proteins: their structure and spatial 
arrangement in prokaryotic ribosomes. Adv. Protein Chem. 36: 
1-77. 
Gish, W., and D.J. States. 1993. Identification of protein coding 
regions by database similarity search. Nature Genet 3:266-272. 
Guddat, U., A. H. Bakken., and T. Pieler. 1990. Protein-
mediated nuclear export of RNA:rRNA containing smaU RNPs in 
Xenopus oocytes. Cell 60:619-628. 
147 
References 
Hampl, H., H. Schulze, and K. H. Nierhaus. 1981. Ribosomal 
components from E, coli 50S subunits involved in the 
reconstitution of peptidyltransferase activity. J. Biol Chem. 
256:2284-2288. 
Hanahan, D. 1985. Techniques for transformation of Escherichia 
coli In DNA cloning: A practical approach (ed. D. M. Glover), vol. 
1, p.l09. IRL Press, Oxford, UK. 
Hariharan, N., D.E. KeUey, and R.P. Perry. 1989. Equipotent 
mouse ribosomal protein promoters have a similar architecture 
that includes intemal sequence elements. Genes and Dev. 
3:1789-1800. 
Held, W.A., B. BaUou, S. Mizushima, and M. Nomura. 1974. 
Assembly mapping of 30S ribosomal proteins from Escherichia 
coli J. Biol Chem. 249:3103-3111. 
Hopp, T.P., and K.R. Woods. 1981. Prediction of protein 
antigenic determinants from amino acid sequences. Proc. Natl 
Acad. Sci. USA. 78:3824-3828. 
Huynh, T.V., R.A. Young, and R.W. Davis. 1985. Constructing 
and screening cDNA Ubraries in XgtlO and Xgtll, In Glover, 
D.M. (ed), DNA cloning voL 1，IRL Press, Oxford, p49-78. 
Hwang, D.M., Y.W. Fung, R.X. Wang, C.M. Laurenssen, S.H. Ng, 
W.Y. Lam, K.W. Tsui, K.P. Fung, M. Waye, C.Y. Lee, and C.C. 
Liew. 1995. Analysis of expressed sequence tags from a fetal 
human heart cDNA Ubrary. Genomics. 30:293-298. 
Ito, K., D. P. Cerretti, H. Nashimoto, and M. Nomura. 1984. 
Characterization of an amber mutation in the structural gene for 
ribosomal protein L15 which impairs the expression of the protein 
export gene, secY, in E. coli EMBOJ. 3:2319-2324. 
Itoh, T., K. Higo, and E. Otaka. 1979. Isolation and 
characterization of twenty-three ribosomal proteins from large 
subunits ofyeast. Biochemistry. 18:5787-91. 
Kenmochi, N., N. Maeda, and T. Tanaka. 1992. The structure 
and complete sequence of the gene encoding chicken ribosomal 
protein L5. Gene. 119:215-219. 
148 
References 
Khan, A.S., A.S. Wilcox, M.H. Polymeropoulos, J.A. Hopkins, T.J. 
Stevens, M. Robinson, A.K. Orpana, and J.M. Sikela. 1992. Single 
pass sequencing and physical and genetic mapping of human 
brain cDNAs. Nature Genet 2:180-185. 
Khouri, R. E., M. Lewis, D. F. Barker, D. Band, J. N. Nguyen, K. 
N., T. Maclemore, and J. J. Wasmuth. 1989. Mapping 14 
human gene sequences with a commerciaUy available somatic 
ceU hybrid panel. Cytogenet Cell Genet 51:1025. 
Kirby, M.L., G. Cheng, H. Stadt, and G. Hunter. 1995. 
Differential expression of the L10 ribosomal protein during 
heart development. Biochem, Biophys. Res. Comm. 212:461-465. 
Kim, J. K., and R. Wu. 1993. A rice (Oryza sativum L.) cDNA 
encodes a protein sequence homologous to the eukaryotic 
ribosomal 5S RNA binding protein gene. Plant Mol Biol 23:409-
413. 
Kondoh, N., C.L. Schweinfest, K.W. Henderson, and T.S. Papas. 
1992. Differential expression of S19 ribosomal protein, laminin-
binding protein, and human lymphocyte antigen class I 
messenger RNAs associated with colon carcinoma progression 
and differentiation. CancerRes. 52:791-796. 
Konishi, K., Y. Morishima, and E. Ueda, et al 1994. Cataloging 
of the genes expressed in human keratinocytes: analysis of 607 
randomly isolated cDNA sequences. Biochem. Biophys, Res. 
Commun. 202:976-983 
Kozak, M. 1986 Point mutation define a sequence flanking the 
AUG initiator codon that modulates translation by eukaryotic 
ribosomes. Cell 44:283-292. 
Kuwano, Y., J. Olvera, and I.G. Wool. 1992. The primary 
structure of rat ribosomal protein S5. J. Biol. Chem. Vol. 267, 
No. 35:25304-25308. 
LaemmU, U.K. 1970. Cleavage ofthe structural proteins during the 
assembly ofthe head ofbacteriophage T4. Nature. 227:680-685. 
149 
References 
Law, P.T.W., S.K.W. Tsui, W.Y. Lam, S.C.W. Luk, D.M. Hwang, 
C.C. Liew, C.Y. Lee, K.P. Fung, and M.M.Y. Waye. 1996. A novel 
cDNA encoding a human homologue of ribosomal protein L29. 
Biochim. Biophys. Acta. 1305:105-108. 
Lee, S.W., C. Tomasetto, and R. Sager. 1991. Positive selection of 
candidate tumor-suppressor genes by subtractive hybridization. 
Proa NatL Acad. ScL USA. 88:2825-2829. 
Lee-Chuan C. Y., and J. C. Lee. 1995. Contributions of multiple 
basic amino acids in the C-terminal region of yeast ribosomal 
protein L1 to 5S rRNA binding and 60S ribosome stabiUty. J. 
Mol Biol 246:295-307. 
Liew, C.C. 1993. The development of an efficient and simple 
method for automated DNA sequencing. J. Mol Cell Cardiol 
25:891-894. 
Liew, C.C., D.M. Hwang, Y.W. Pung, C. Laurenssen, E. 
Cukerman, S. Tsui, and C.Y. Lee. 1994. A catalogue of genes in 
the cardiovascular system as identified by expressed sequence 
tags. Proa Natl. Acad, ScL USA. 91:10645-10649. 
Lopez, R., T. Kristensen, and H. Prydz. 1992. Database 
contamination. Nature, 355:211. 
Lotti, M., E. R. Dabbs, R. Hasenbank, M. Stoffler-MeiHcke, and G. 
Stoffler. 1983. Characterization of a mutant from E. coli lacking 
protein L15 and locaHzation of protein L15 by immuno-electron 
microscopy. Mol Gen. Genet 192:295-300. 
Mariottini, P., and F. Amaldi. 1990.The 5，untranslated region of 
mRNA for ribosomal protein S19 is involved in its translational 
regulation during Xenopus development. Mol Cell Biol. 10:816-
822. 
Matheson, A. T. 1985. Ribosomes of the archaebacteria, p. 345-
377. In C. R. Woese and R.S. WoMie (ed.), The Bacteria: a Treatise on 
Structure and Function, vol. 8. Academic Press, Orlando, Florida. 
Monk, R.J., 0. Meyuhas, and R.P. Perry. 1984. Mammals have 




Moore, K.L. 1982. The Developing Human. 3rd edition. (W.B. 
Saunders Company), p. 302-306. 
Moritz, M., A.G. Paulovich, Y.-F. Tsay, and J.L. WooUbrd Jr. 
1990. Depletion of yeast ribosomal proteins L16 or rp59 
disrupts ribosome assembly. J. Cell Biol 111:2261-2274. 
Neu, E., A.H. Von Mikecz, P.H. Hemmerich, H.-H. Peter, M. 
Fricke, H. Deicher, E. Genth, U. Krawinkel, and members of the 
sle study group. 1995. Autoantibodies against eukaryotic 
protein L7 in patients suffering from systemic lupus 
erythematosus and progressive systemic sclerosis: frequency 
and correlation with cUnical, serological and genetic parameters. 
Clin. Exp. Immunol 100:198-204. 
Nierhaus, K. H. 1980. Analysis ofthe assembly and function ofthe 
50S subunit from Escherichia coli ribosomes by reconstitution, p. 
267-294. In G. ChambUss, G. R. Craven, J. Davies, K. Davis, L. 
Kahan, and M. nomura (ed.), Ribosomes: Structure, Function, and 
Genetics. University Park Press, Baltimore. 
NoUer, H. F. 1984. Structure of ribosomal RNA. Annu, Rev. 
Biocherru 53:119-162. 
NoUer, H.F., M. Asire, A. Barta, S. Douthwaite, T. Goldstein, 
R.R. GuteU, D. Moazed, J. Normanly, J. B. Prince, S. Stem, K. 
Triman, S. Tumer, B. Van StoDi, V. Wheaton, B. Weiser, and 
C.R. Woese. 1986. Studies on the structure and function of 
ribosomal RNA, p. 143-163. In B. Hardesty and G. Kramer (ed.), 
Structure, function, and Genetics of Ribosomes. Springer-Verlag, 
New York. 
Okubo, K., N. Hori, R. Matoba, T. Niiyama, A. Fukushima, Y. 
Kojima, and K. Matsubara. 1992. Large scale cDNA sequencing for 
anatysis of quantitative and quaHtative aspects of gene expression. 
Nature Genet 2:173-179. 
Olson, M., L. Hood, C. Cantor, and D. Botstein. 1989. A common 




Otaka, E., K. Higo, and T. Itoh. 1984. Yeast ribosomal proteins. 
Mol Gen. Genet 195:544-546. 
Paz, V., J. Olvera, Y. L. Chan, and LG. Wool. 1989. The primary 
structure ofrat ribosomal protein L26. FEBS Lett 251:89-93. 
Planta, R. J., W. H. Mager, R. J. Leer, L. P. Woudt, H. A. Raue, and 
T. T. A. L. El-Baradi. 1986. Structure and expression of ribosomal 
protein genes in yeast, p. 699-718. In B. Hardesty and G. Kramer 
(ed.), Structure, Function, and Genetics of Ribosomes. Springer-
Verlag, New York. 
Pogue-GeUe K., J.R. Gieser, M. Shu, C. MiUer, I.G. Wool, A.I. 
Meisler, and J.M. Pipas. 1991. Ribosomal protein genes are 
overexpressed in colorectal cancer: isolation of a cDNA clone 
encoding the human S3 ribosomal protein. Mol Cell Biol. 
11:3842-3849. 
Pohl, T., and Wittmann-Liebold. 1988. Identification of a cross-Knk 
in the Escherichia coHribosomal protein pair S13-S19 at the amino 
acid level. J. Biol Chenu 263:4293-4301. 
Polakiewicz, R.D., D.J. Munroe, S.N.J. Sait, K.T. lVcowski, N.J. 
Nowak, T.B. Shows, D. E. Housman, and D. C. Page. 1995. 
Mapping of ribosomal protein S3 and internaUy nested snoRNA 
U15A gene to human chromosome llql3.3-ql3.5. Genomics. 
25:577-580. 
Powers, T., L.-M. Changchien, G.R. Craven, and H.F. NoUer. 
1988. Probing the assembly of the 3’ major domain of 16S 
ribosomal RNA. Quaternary actions involving ribosomal proteins 
S7, S9 and S19. J. Mol Biol. 200:309-319. 
Proudfoot, N.J., and G.G. Brownlee. 1976. 3，non-coding region 
sequences in eukaryotic messenger RNA. Nature, 263:211-214. 
Reich, C., G. J. Olsen, B. Pace, and N. R. Pace. 1988. The role of 
the protein moiety of ribonuclease P, a ribonucleoprotein enzyme. 
Science. 239:178-181. 
Safrany, G., and R.P. Perry. 1995. The relative contributions of 
various transcription factors to the overaU promoter strength of 
152 
References 
the mouse ribosomal protein L30 gene. Eur. J. Biochem. 
230:1066-1072. 
Saha, D.P., P.S. Tirumalai, L.A. ScaIa, and R.D. HoweU. 1993. 
Human ribosomal protein L37a: cloning of the cDNA and 
analysis of differential gene expression in tissues and ceU Unes. 
Gene. 132: 285-289. 
Sambrook, J., E. F. Fritsch, and T. Maniatic. 1989. Molecular 
cloning (2nd Ed. Cold Spring Harbor Laboratory). Cold Spring 
Harbor, N. Y. 
Schmidtke, J., and D. N. Cooper. 1990. A comprehensive list of 
cloned human DNA sequences. Nucleic. Acids Res. 18, 2413-
2414. 
Schuke, H., and K. H. Nierhaus. 1982. Minimal set of ribosomal 
components for reconstitution of the peptidyltransferase activity. 
EMBOJ. 1:609-613. 
Stewart, M.J., and G. Thomas. 1994. Mitogenesis and protein 
synthesis: A role for ribosomal protein S6 phosphorylation? 
BioEssay. 11:809-815. 
Sudo, K., K. Chinen, and Y. Nakamura. 1994. 2,058 expressed 
sequence tags (ESTs) from a human fetal lung cDNA library. 
Genomics. 24:276-279. 
Sun, D., S. Kar, and B.L Carr. 1995. DifferentiaUy expressed 
genes in TGF-pl sensitive and resistant human hepatoma ceUs. 
CancerLeU. 89:73-79. 
Suzuki, K., J. Olvera, and I.G. Wool. 1990. The primaiy structure 
of rat ribosomal protein S13. Biochem Biophys. Res. Comm. 
171:519-524. 
The QIAexpressionist: The high level expression and protein 
purification system. Summer 1992. 
Travis, F.H., and J.G. SutcMe. 1988. Phenol emvdsion-enhanced 
DNA-driven subtraction cDNA cloning: isolation of low-abundance 




Tsui S. K. W., Y.W. Fung, P. T. W. Law, W. Y. Lam, M. M. Y. 
Waye, C. Y. Lee, and C. C. Liew. 1994a. Large scale cDNA 
sequencing to analyze gene expression in human heart. J. Mol 
Cell Cardiol 26:CLXXVI. 
Tsui S. K. W., H. K. Y. Cheung, P. T. W. Law, W. Y. Lam, C. Y. 
Lee, A. S. Y. Lo, V. W. Y. Lui, S. C.W. Luk, K. C. Tung, N. Y. H. 
Yam, and M. M. Y. Waye. 1994b. Gene expression in adult 
human heart revealed by random cDNA sequencing of cDNA 
Ubrary. Abstract in Annual Scientific Meeting of Hong Kong 
Society for Immunology^ Oct. 29, Hong Kong. 
Von Mikecz, A.H., P.H. Hemmerich, H.-H Peter, and U. 
Krawinkel. 1995. Autoantigenic epitopes on eukaryotic L7. Clin. 
Exp. Immunol 100:205-213. 
WaUeczek, J” D. Schiiler, M. Stoffler-MeiUcke, R. Brimacombe, 
and G. St6ffler. 1988. A model for the spatial arrangement of the 
proteins in the large subunit of the Escherichia coli ribosome. 
BMBO J. 7:3571-3576. 
Wamer, J. R. 1989. Synthesis of ribosomes in Saccharomyces 
cerevisiae. Microbiol Rev, 53:256-271. 
White R. and J.M. LaloueL 1988. Chromosome mapping with DNA 
markers. ScL Am. 258:20-28. 
Wilcox, A.S., A.S. Khan, J.A. Hopkins, and J.M. Sikela. 1991. Use 
of 3’ untranslated sequences of human cDNAs for rapid 
chromosome assignment and conversion to STSs: impUcations for 
an expression map of the genome. Nucleic Acids Res. 19:1837-
1843. 
Wintermeyer, W., and C. Gualerzi. 1983. Effect of Escherichia coli 
initiation factors on the kinetics of N-AcPhe-tRNAPhe binding to 
30S ribosomal subunits. A fluorescence stopped-flow study. 
Biochemistry, 22:690-694. 
Wittmann, H.G. 1986. Structure of ribosomes, p. 1-27. In B. 
Hardesty and G. Kratner (ed.), Structure, Function, and Genetics 
of Ribosomes. Springer-Verlag, New York. 
154 
References 
Wittmann-Liebold, B. 1984. Primaiy structure of Escherichia coli 
ribosomal proteins. Adv. Protein Chem. 36:56-78. 
Wittman-Uebold, B., K. Ashman, and M. Dzionara. 1984. On the 
statistical significance of homologous structures among the 
Escherichia coli ribosomal proteins. Mol Gen, Genet 196:439-
448. 
Wittman-Liebold, B. 1986. Ribosomal proteins: their structure 
and evolution, p. 326-361. In B. Hardesty and G. Kramer (ed.), 
Structure, function, and Genetics of Ribosomes, Springer-Verlag, 
New York. 
Woese, C.R., and G.E. Fox. 1977. The concept of ceUular 
evolution. Mol Evol. 10:1-6. 
Woese, C.R., and G.J. Olsen. 1986. Archaebacterial phylogeny: 
perspectives on the urkingdoms. Syst. Appl. Microbiol 7:161-
177. 
Wool, LG., and G. Stoffler. 1974. Structure and function of 
eukaryotic ribosomes. In Ribosomes (ed. M. Nomura, A. 
Tissieres. and P. Lengyel), p.417-460. Cold Spring Harbor 
Laboratory. 
Wool, I.G. 1979. The structure and function of eukaryotic 
ribosomes. Annu. Rev. Biochem. 48:719-754. 
Wool, LG., Y. Endo, Y.L. Chan, and A. Glilck. 1990 in The 
Ribosome: Structure, Function, and Evolution (HiU, W.E., et al 
ed.), p. 203-214, Amer. Soc. Microbiol” Washington, D.C. 
Zach O.R.F., H. Bauer, K. Richter, G. Webersinke, and H. 
Bauer. 1995. Sequence ofthe porcine fuU-length cDNA encoding 



















•考" p  :/  ^  V  •  .  .  I  
,
. 
































 - ^ 4 ^  .  1  .  .  .  -  ;
r













 \  f  ’  .  .  /  
, -  . • .  \  
. y  .?,、.：
-“  " 














 一  .

















 .  •  . 
- . . .  -  ^  -
-. 
.
































.  - • •  :
、 
V  .  ,
" 











\ ! _  +  ..-  .  . 
^  . 
i .  r  




i  .  •  • 




 •.  .  .  . 




J .  7 .  ....1  ^ .,、：_v-
. 
,  .  , ... 
.
.





V .  :  .  ,  .  . .  _ - "  






 •  .  , . y ^  v
.
-














 .  .  -  .  r  . i  z  4  」  ，  r  . 
i  ^  t f  ^  ？.  ,. 
• • 1 
CUHK L i b r a r i e s 
_ni_iii_i 
••B511D5E 
